tyrosine has been researched along with angiotensin ii in 244 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 45 (18.44) | 18.7374 |
| 1990's | 84 (34.43) | 18.2507 |
| 2000's | 87 (35.66) | 29.6817 |
| 2010's | 25 (10.25) | 24.3611 |
| 2020's | 3 (1.23) | 2.80 |
| Authors | Studies |
|---|---|
| Daurat-Larroque, ST; Portuguez, ME; Santomé, JA | 1 |
| Goissis, G; Nakaie, CR; Oshiro, ME; Paiva, AC | 1 |
| Miller, JH; Smail, GA | 1 |
| Escher, E; Guillemette, G | 1 |
| Bumpus, FM; Khairallah, PA; Khosla, MC; Plucinska, K; Stachowiak, K | 1 |
| Chervu, LR; Murty, DR | 1 |
| Ishida, Y; Kawahara, Y; Koide, M; Shii, K; Tsuda, T; Yokoyama, M | 2 |
| Ishida, Y; Kawahara, Y; Koide, M; Tsuda, T; Yokoyama, M | 1 |
| Dy, RC; Earp, HS; Huckle, WR | 1 |
| Berk, BC; Corson, MA; Duff, JL | 1 |
| Earp, HS; McCune, BK; Prokop, CA | 1 |
| Earp, HS; Harden, TK; Hepler, JR; Huckle, WR; Jeffs, RA; Outlaw, HE; Rhee, SG | 1 |
| Dy, RC; Earp, S; Herman, B; Huckle, WR; Prokop, CA | 1 |
| Avruch, J; Bonventre, JV; Force, T; Kyriakis, JM | 1 |
| Hsu, CY; Hurwitz, DR; Mervic, M; Zilberstein, A | 1 |
| Dudley, DT; Hubbell, SE; Summerfelt, RM | 1 |
| Matsoukas, JM; Moore, GJ; Turner, RJ | 1 |
| Boutin, JA; Ernould, AP; Ferry, G; Genton, A | 1 |
| MacLean, MR; Raizada, MK; Sumners, C | 1 |
| Hagiwara, M; Hongo, K; Kobashi, K; Morikawa, T; Ohuchi, E; Oki, M; Wada, K | 1 |
| Corvera, S; Czech, MP; Mottola, C; Whitehead, RE | 1 |
| Ohmura, Y; Teraoka, H; Tsukada, K | 1 |
| Lu, PW; Tao, M | 1 |
| Baltimore, D; Chow, M; Foulkes, JG; Frackelton, AR; Gorka, C | 1 |
| Abhold, RH; Harding, JW | 1 |
| Khosla, MC; Kiso, Y; Kono, T; Sakura, N | 1 |
| Alekseenko, LP; Orekhovich, VN | 1 |
| Montgomery, R; Zaheer, A; Zaheer, S | 1 |
| Franklin, KJ; Goghari, MH; Matsoukas, JM; Moore, GJ; Scanlon, MN | 1 |
| Moore, GJ | 1 |
| Cohen, LA; Farber, L | 1 |
| Bumpus, FM; Sivanandaiah, KM; Smeby, RR | 1 |
| Doyle, AE; Murray, M; Osborn, EC | 1 |
| Craig, LC | 1 |
| Cowgill, RW | 1 |
| Boadle, MC; Hughes, J; Roth, RH | 1 |
| Delius, AE; Franze de Fernández, MT; Paladini, AC | 1 |
| Akutsu, H; Fujimoto, S; Hiwada, K; Kokubu, T; Ueda, E; Yamamura, Y | 1 |
| Bumpus, FM; Chaturvedi, NC; Park, WK; Smeby, RR | 1 |
| Glauser, EM; Glauser, SC; Sevy, RW; Wagner, H | 1 |
| Palaić, D | 1 |
| Abrash, L; Marks, N; Walter, R | 1 |
| Masson, GM; Nasjetti, A | 1 |
| Logunov, AI; Orekhovich, VN | 1 |
| Bumpus, FM; Khosla, MC; Kumar, S; Smeby, RR | 1 |
| Masson, GM; Nasjletti, A | 1 |
| Freer, RJ; Marshall, GR; Needleman, P | 1 |
| Hughes, J; Roth, RH | 1 |
| Boadle-Biber, MC; Hughes, J; Roth, RH | 1 |
| Baum, T; Shropshire, AT | 1 |
| Bleich, HE; Craig, LC; Galardy, RE; Printz, MP | 1 |
| Koerner, T; O'Donoghue, JK; Oparil, S | 1 |
| Limas, CJ | 1 |
| Boschcov, P; Juliano, L; Paiva, AC | 1 |
| Davila, D; Khairallah, PA | 1 |
| Bernier, M; Escher, E; Guillemette, G; Leduc, R; Parent, P | 1 |
| Fox, JW; Tu, AT | 1 |
| Giasson, E; Haddad, P; Leduc, I; Meloche, S | 1 |
| Butcher, RD; Marmé, D; Schöllmann, C | 1 |
| Bardhan, S; Inagami, T; Kambayashi, Y; Shirai, H; Takahasi, K | 1 |
| Donella-Deana, A; Klee, C; Krinks, MH; Pinna, LA; Ruzzene, M | 1 |
| Earp, HS; Huckle, WR | 1 |
| Molloy, CJ; Taylor, DS; Weber, H | 2 |
| Kanaide, H; Kobayashi, S; Nishimura, J | 1 |
| Berk, BC; Bernstein, KE; Delafontaine, P; Klein, JD; Marrero, MB; Paxton, WG | 1 |
| Hanks, SK; Naftilan, AJ; Polte, TR | 1 |
| Baker, KM; Bhat, GJ; Conrad, KM; Thekkumkara, TJ; Thomas, WG | 1 |
| Ahmad, S; Hollenberg, MD; Laniyonu, A; Saifeddine, M | 1 |
| Giasson, E; Meloche, S | 1 |
| Molloy, CJ; Pietras, KM; Taylor, DS; Turner, CE | 1 |
| Bernstein, KE; Marrero, MB; Paxton, WG; Schieffer, B; Schieffer, E | 1 |
| Carvalho, CR; Saad, MJ; Velloso, LA | 1 |
| Clunn, GF; Hughes, AD; Schachter, M | 1 |
| Chap, H; Conté, JJ; Delobbe, I; Fauvel, J; Gayral-Taminh, M; Mignon-Conté, M; Salles, JP | 1 |
| Budde, RJ; Dyckes, DF; McMurray, JS | 1 |
| Balla, T; Bor, M; Catt, KJ; Hunyady, L | 1 |
| Berk, BC; Bernstein, KE; Delafontaine, P; Heerdt, L; Marrero, MB; Paxton, WG; Schieffer, B | 1 |
| Leduc, I; Meloche, S | 1 |
| Izumo, S; Morgan, JP; Qiu, Z; Sadoshima, J | 1 |
| Baker, KM; Conrad, KM; Madigan, NN; Peeler, TC; Schorb, W | 1 |
| Kent, KC; Mallette, SA; Mii, S; Ware, JA | 1 |
| Alexander, RW; Griendling, KK; Kai, H; Lassègue, B; Ollerenshaw, JD; Runge, MS | 1 |
| Berk, BC; Bernstein, KE; Duff, JL; Marrero, MB; Paxton, WG | 1 |
| Boarder, MR; Morton, C; Wilkie, N | 1 |
| Berk, BC; Bernstein, KE; Duff, JL; Marrero, MB; Paxton, WG; Schieffer, B | 1 |
| Bernstein, KE; Marrero, MB; Paxton, WG; Schieffer, B | 1 |
| Edmonds, CG; Fuciarelli, AF; Springer, DL; Weir Lipton, MS | 1 |
| Damen, JE; Goutsouliak, V; Krystal, G; Rabkin, SW | 1 |
| Bernstein, KE; Ling, BN; Marrero, MB; Schieffer, B | 1 |
| Gould, GW; Malarkey, K; McLees, A; Paul, A; Plevin, R | 1 |
| Bernstein, KE; Ling, BN; Ma, H; Marrero, MB; Schieffer, B | 1 |
| Bank, RA; Beekman, B; Jansen, EJ; te Koppele, JM | 1 |
| Folli, F; Kahn, CR; Saad, MJ; Sun, XJ; Velloso, LA; White, MF | 1 |
| Kooy, NW; Lewis, SJ | 1 |
| Alexander, RW; Griendling, KK; Lassègue, B; Ushio-Fukai, M | 1 |
| Alexander, RW; Griendling, KK | 1 |
| Bernstein, KE; Harp, JB; Marrero, MB; Sayeski, PP; Scanlon, M | 1 |
| Ali, MS; Bernstein, KE; Delafontaine, P; Ling, BN; Marrero, MB; Schieffer, B | 1 |
| Kerwin, JL | 1 |
| Maloney, JA; Pei, Z; Williamson, JR; Yang, L | 1 |
| Ali, MS; Bernstein, KE; Dirksen, LB; Hayzer, DJ; Marrero, MB; Sayeski, PP | 1 |
| Baker, KM; Conrad, KM; Dostal, DE; Hunt, RA; McWhinney, CD | 1 |
| Berk, BC; Ishida, M; Schmitz, U | 1 |
| Abe, J; Deguchi, J; Kurokawa, K; Makuuchi, M; Matsumoto, T; Noda, M; Ohno, M; Takuwa, N; Takuwa, Y | 1 |
| Apostolidis, A; Weiss, RH | 1 |
| Aboulafia-Etzion, S; Aharonovitz, O; Battler, A; Granot, Y; Leor, J | 1 |
| Fukuda, K; Hori, S; Kodama, H; Makino, S; Ogawa, S; Pan, J; Sano, M; Takahashi, T | 1 |
| Kawahara, Y; Takahashi, T; Taniguchi, T; Yokoyama, M | 1 |
| Baker, K; Dostal, D; McWhinney, CD | 1 |
| Ali, MS; Bernstein, KE; Harp, JB; Marrero, MB; Sayeski, PP | 1 |
| Ali, MS; Bernstein, KE; Lyles, M; Safavi, A; Sayeski, PP | 1 |
| Byron, KL; Govindarajan, G; Griffin, TM; Lucchesi, PA; Sabri, A; Samarel, AM | 1 |
| Eaton, DC; Marrero, MB; Venema, RC; Venema, VJ | 1 |
| Fujio, Y; Kishimoto, T; Kunisada, K; Matsui, H; Negoro, S; Oh, H; Tone, E; Yamauchi-Takihara, K | 1 |
| Baker, KM; Bhat, GJ | 1 |
| Ali, MS; Bernstein, KE; Doan, TN; Sayeski, PP; Semeniuk, DJ | 1 |
| Kim, SY; Lee, HK; Park, DJ | 1 |
| Deng, LY; He, G; Schiffrin, EL; Touyz, RM | 1 |
| Feng, YH; Husain, A; Karnik, SS; Miura, S | 1 |
| Bertics, PJ; Patel, TB; Poppleton, HM; Wiepz, GJ | 1 |
| Jendral, M; Ullrich, V; Zou, M | 1 |
| Baker, KM; Booz, GW; Carl, LL | 1 |
| Bachschmid, M; Zou, MH | 1 |
| Ford, CM; Li, S; Pickering, JG | 1 |
| Amiri, F; Ju, H; Marrero, MB; Venema, RC; Venema, VJ; Wang, X | 1 |
| Bauer, JA; Holycross, BJ; Wattanapitayakul, SK; Weinstein, DM | 1 |
| Inagami, T; Landon, EJ; Tang, H; Zhao, ZJ | 1 |
| Ali, MS; Bernstein, KE; Sayeski, PP | 1 |
| Brockman, D; Eis, A; Kossenjans, W; Myatt, L; Sahay, R | 1 |
| Blume, A; Mielke, K; Stroth, U; Unger, T | 1 |
| Davis, J; Schiebinger, R; Yingst, DR | 1 |
| Baba, A; Hashimoto, H; Koyama, Y; Matsuda, T; Yoshioka, Y | 1 |
| Anversa, P; Chimenti, C; Frustaci, A; Jakoniuk, I; Kajstura, J; Leri, A; Maseri, A; Nadal-Ginard, B | 1 |
| Ali, MS; Bernstein, KE; Frank, SJ; Sayeski, PP | 1 |
| Bloom, DC; Fang, X; Fluharty, SJ; Hines, J; Kratz, E; Maher, P; Mizukoshi, E; Moffett, J; Myers, J; Peng, H; Stachowiak, EK; Stachowiak, MK | 1 |
| Beier, I; Düsing, R; Sachinidis, A; Schmitz, U; Thömmes, K; Vetter, H; Wagner, W | 1 |
| Alexander, RW; Becker, PL; Griendling, KK; Halleran, S; Hilenski, L; Ushio-Fukai, M | 1 |
| Ali, MS; Bernstein, KE; Doan, TN | 1 |
| Cayatte, AJ; Cohen, RA; Du, Y; Johns, DG; Quinn, MT; Wang, HD; Xu, S | 1 |
| Burns, KD; Chen, JK; Harris, RC; Zimpelmann, J | 1 |
| Andreoli, AM; Anversa, P; Chimenti, S; Fiordaliso, F; Kajstura, J; Leri, A; Li, B; Limana, F; Medow, MS; Nadal-Ginard, B | 1 |
| Caidahl, K; Kalume, DE; Petersson, AS; Roepstorff, P; Steen, H | 1 |
| Guillemot, L; Levy, A; Raymondjean, M; Rothhut, B | 1 |
| Hill, MA; Murphy, TV; Spurrell, BE | 1 |
| Kirima, K; Kyaw, M; Suzaki, Y; Tamaki, T; Tsuchiya, K; Yoshizumi, M | 1 |
| Dobrian, AD; Prewitt, RL; Schriver, SD | 1 |
| Alexander, RW; Becker, PL; Griendling, KK; Hilenski, L; Ma, Y; Santanam, N; Ushio-Fukai, M | 1 |
| Ando, K; Fujita, T; Ishibashi, K; Kangawa, K; Kato, S; Kitamura, K; Shibagaki, Y; Shimosawa, T | 1 |
| Cohen, RA; Johns, DG; Wang, HD; Xu, S | 1 |
| Chikara, S; Fukuda, N; Hu, WY; Kanmatsuse, K; Kishioka, H; Nakayama, M; Teng, J | 1 |
| Jin, SG; Lea, JP; Marrero, MB; Roberts, BR; Shuler, MS; Tumlin, JA | 1 |
| Fan, YP; Puri, RN; Rattan, S | 1 |
| Arruda, JA; Bernardo, AA; Espiritu, DJ; Robey, RB | 1 |
| Bencherif, M; Marrero, MB; Shaw, S | 1 |
| Coulombe, P; Duhamel, F; Meloche, S; Pelletier, S; Popoff, MR | 1 |
| Bauer, JA; Hoyt, DG; Mihm, MJ; Piao, SF; Wattanapitayakul, SK | 1 |
| Alexander, GD; Isales, CM; Marrero, MB; Redd, H; Shaw, S; Wang, X | 1 |
| Bill, HM; Galante, LM; Mack, CP; Sundberg, LJ; Taylor, JM | 1 |
| Adachi, T; Cohen, RA; Guo, W; Jiang, B; Kirber, M; Lieberthal, W; Matsui, R; Xu, S; Zou, MH | 1 |
| Banes, AK; Marrero, MB; Schmidt, AM; Shaw, SS; Stern, DM; Wang, X | 1 |
| Bezerra, RM; Calegari, VC; Franchini, KG; Saad, MJ; Torsoni, AS; Torsoni, MA; Velloso, LA | 1 |
| DEODHAR, SD | 1 |
| POUCHAN, MI; VILALLONGA, F | 1 |
| Aebersold, R; Berk, BC; Haendeler, J; Heller, M; Hojo, Y; Melaragno, M; Saito, Y; Sharma, VK; Yan, C; Yin, G | 1 |
| Akers, ML; Alexander, RW; Griendling, KK; Hemmings, BA; Hilenski, L; Park, J; Rocic, P; Taniyama, Y; Weber, DS | 1 |
| Alvarez, SE; Ciuffo, GM; Fuentes, LB | 1 |
| Bencherif, M; Bhatti, BS; Marrero, MB; Papke, RL; Shaw, S | 1 |
| Ali, N; Fujita, Y; Ishimura, K; Izawa, Y; Kagami, S; Kanematsu, Y; Kyaw, M; Tamaki, T; Toida, K; Tsuchiya, K; Yoshizumi, M | 1 |
| Chatterjee, S; Freedman, RR; Furspan, PB | 1 |
| Gavini, N; Mandavia, CH; Pulakat, L | 1 |
| Erdélyi, M; Frändberg, PA; Hallberg, A; Johannesson, P; Karlén, A; Lindeberg, G; Nyberg, F | 1 |
| Ostrov, DA; Sandberg, EM; Sayeski, PP; VonDerLinden, D | 1 |
| Ikeda, K; Xu, JW; Yamori, Y | 1 |
| Callera, GE; He, Y; Javeshghani, D; Lochard, N; Mercure, C; Reudelhuber, TL; Touyz, RM; Yao, G; Yogi, A | 1 |
| Derbyshire, ZE; Halfter, UM; Heimark, RL; Sy, TH; Vaillancourt, RR | 1 |
| Ali, N; Ebina, Y; Fujita, Y; Ishizawa, K; Izawa, Y; Kanematsu, Y; Obata, T; Tamaki, T; Tomita, S; Tsuchiya, K; Yoshizumi, M | 1 |
| Madeddu, P | 1 |
| Hashikabe, Y; Hattori, Y; Kase, H; Nakanishi, N; Uchida, K | 1 |
| Alexander, RW; Hilenski, L; Ikeda, S; Patrushev, N; Ushio-Fukai, M; Zuo, L | 1 |
| Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y | 1 |
| Bottari, SP; Garrido, MR; Levy, P; Pinzar, E; Wang, T; Xu, W | 1 |
| Beckles, DL; Mascareno, E; Siddiqui, MA | 1 |
| Kim, CH; Quiroz, Y; Rodriguez-Iturbe, B; Vaziri, ND | 1 |
| Murad, F; Turko, IV | 1 |
| Jácamo, RO; Rozengurt, E; Vong, SK; Wu, SS | 1 |
| Chen, YJ; Li, J; Quilley, J | 1 |
| Johnston, MV; Laskin, J; Lloyd, JA; Spraggins, JM | 1 |
| Galeotti, J; Holle, E; Liu, J; Sadoshima, J; Wagner, T; Yu, X; Zhai, P | 1 |
| Alvarez, SE; Ayub, MJ; Ciuffo, GM; Villarreal, RS | 1 |
| Ando, K; DiPette, DJ; Fujita, T; Liu, J; Matsui, H; Meng, F; Shimosawa, T; Supowit, SC | 1 |
| Boldogh, I; Brasier, AR; Hou, T; Lee, CY; LeJeune, WS; Lu, M; Recinos, A; Sun, H; Tieu, BC; Tilton, RG | 1 |
| Deng, H | 1 |
| Anrather, J; Girouard, H; Iadecola, C; Park, L; Zhou, P | 1 |
| Hayashi, Y; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K | 1 |
| Caidahl, K; Delbro, D; Hultman, L; Højrup, P; Söderling, AS | 1 |
| Kim, KP; Kim, YH; Lee, JR; Lee, SJ; Park, HS; Park, SI; Park, YS | 1 |
| Avila-Casado, MC; Escalante, B; Medina, A; Rios, A; Robles, HV; Romo, E; Sanchez-Mendoza, A; Soto, V | 1 |
| Dass, C; Jalili, PR | 1 |
| Dempsey, PJ; Eguchi, K; Eguchi, S; Frank, GD; Higuchi, S; Hinoki, A; Inagami, T; Nakashima, H; Ohtsu, H; Reyland, ME; Sanjay, A; Shirai, H | 1 |
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Yoshida, K | 1 |
| Aroor, AR; Shukla, SD; Weng, YI | 1 |
| Berger, A; Holz, S; Mueller, CF; Nickenig, G; Wassmann, K; Wassmann, S | 1 |
| Bertorello, AM; Budu, CE; Efendiev, R; Pedemonte, CH | 1 |
| Slutsky, AS; Syeda, F; Tullis, E; Zhang, H | 1 |
| Dominici, FP; Giani, JF; Gironacci, MM; Muñoz, MC; Turyn, D | 1 |
| Andersson, H; Demaegdt, H; Hallberg, M; Karlén, A; Lindeberg, G; Vauquelin, G | 1 |
| Avila-Casado, C; Franco, M; Johnson, RJ; Nakagawa, T; Rodríguez-Iturbe, B; Sánchez-Lozada, LG; Sautin, YY; Soto, V; Tapia, E | 1 |
| Bierhaus, A; Bozorgmehr, F; Dugi, K; Hamann, A; Humpert, PM; Ibrahim, Y; Kientsch-Engels, R; Kukudov, G; Morcos, M; Nawroth, PP; Oikomonou, D; Pfisterer, F; Rudofsky, G; Sayed, AA; Schlotterer, A; Schneider, J; Schwenger, V; van der Woude, F; Yard, B; Zeier, M | 1 |
| Kagota, S; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tada, Y | 1 |
| Song, P; Wang, S; Wu, Y; Xu, J; Zou, MH | 1 |
| Kinouchi, T; Kitazato, KT; Nagahiro, S; Satomi, J; Shimada, K; Tada, Y; Tamura, T; Yagi, K | 1 |
| Hwang, SA; Jang, SH; Karnik, SS; Kim, M; Kim, MS; Lee, C; Yun, SH | 1 |
| Giachini, FR; Tostes, RC; Webb, RC; Ying, Z | 1 |
| Fisslthaler, B; Fleming, I; Loot, AE; Schreiber, JG | 1 |
| Ferrario, CM; Habibi, J; Hayden, MR; Johnson, MS; Nistala, R; Rehmer, N; Schneider, RI; Sowers, JR; Tilmon, R; Whaley-Connell, A | 1 |
| Brégeon, J; Bril, A; Guilluy, C; Henrion, D; Loirand, G; Loufrani, L; Offermanns, S; Pacaud, P; Retailleau, K; Rolli-Derkinderen, M; Scalbert, E; Torres, RM; Toumaniantz, G | 1 |
| Andrié, RP; Baldus, S; Böger, RH; Didié, M; Ehmke, H; Eschenhagen, T; Freeman, BA; Friedrichs, K; Fu, X; Hazen, SL; Hirsch-Hoffmann, B; Klingel, K; Klinke, A; Lau, D; Lewalter, T; Meinertz, T; Nickenig, G; Reichenspurner, H; Rudolph, TK; Rudolph, V; Schrickel, JW; Schwoerer, AP; Seniuk, A; Sydow, K; Szoecs, K; Treede, H; von Leitner, EC; Wenzel, U; Willems, S; Zimmermann, WH | 1 |
| Bottari, SP; Communi, D; Csibi, A; Müller, N | 1 |
| Kohda, K; Taguchi, R; Tsumoto, H | 1 |
| Daiber, A; Hortmann, M; Jansen, T; Karbach, S; Knorr, M; Münzel, T; Oelze, M; Opitz, B; Schell, R; Schuhmacher, S; Steven, S; Wenzel, P | 1 |
| Bachschmid, MM; Cohen, RA; Ho, YS; Maitland-Toolan, KA; Matsui, R; Xu, S | 1 |
| De Backer, JP; Demaegdt, H; Lukaszuk, A; Szemenyei, E; Tóth, G; Tourwé, D; Vauquelin, G | 1 |
| Demaegdt, H; Lukaszuk, A; Tourwé, D; Van den Eynde, I; Vanderheyden, P; Vauquelin, G | 1 |
| Bae, EH; Kim, SW; Lee, J; Ma, SK | 1 |
| Bordin, L; Calò, LA; Clari, G; Dal Maso, L; Davis, PA; Pagnin, E; Pessina, AC; Rossi, GP | 1 |
| Andreozzi, F; Laino, I; Martino, F; Musca, D; Perticone, F; Perticone, M; Presta, I; Sciacqua, A; Sesti, G; Tassone, EJ | 1 |
| Davidge, ST; Gao, PJ; Jiang, YY; Jin, HY; Kassiri, Z; Ning, G; Oudit, GY; Penninger, JM; Song, B; Yu, HM; Zhong, JC; Zhu, DL | 1 |
| Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV | 1 |
| Bloch, W; Brixius, K; Reuter, H; Schwinger, RH; Streit, U; Wahlers, T | 1 |
| Kong, X; Li, XY; Ma, MZ; Qin, L; Su, Q; Wang, GD; Zhang, DY; Zhang, Y | 1 |
| D'Aquino, K; Feener, EP; King, GL; Li, Q; Maeda, Y; Mima, A; Mizutani, K; Park, K; Rask-Madsen, C; White, MF; Winnay, J | 1 |
| Nakamura, H; Sato, S | 1 |
| Estes, AM; Fang, XR; Gonzalez, FJ; Jennings, BL; Kanu, A; Malik, KU; Moore, JA; Pingili, AK | 1 |
| Conte, D; Minas, JN; Nishiyama, A; Ortiz, RM; Thorwald, MA; Vázquez-Medina, JP | 1 |
| Freeman, BA; Hudmon, A; Johnson, DE; Levitan, ES; Ramaswamy, SS; Schopfer, FJ; Vitturi, DA; Zhou, C | 1 |
| Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Shin, SJ; Yoon, HE | 1 |
| Yang, Y | 1 |
| Ling, WC; Murugan, DD; Mustafa, MR; Vanhoutte, PM | 1 |
| Chen, Y; Fillmore, N; Gao, S; Harrington, J; Liu, P; Murphy, E; Springer, D; Stoehr, A; Wang, X; Yang, Y; Zhang, X; Zhu, J | 1 |
| Craik, DJ; de Veer, SJ; Li, CY; Swedberg, JE; Yap, K | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Benndorf, RA; Dubourg, V; Gekle, M; Schreier, B; Schwerdt, G | 1 |
9 review(s) available for tyrosine and angiotensin ii
| Article | Year |
|---|---|
[Human erythrocyte peptidases].
Topics: Aminopeptidases; Angiotensin II; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Endopeptidases; Endorphins; Erythrocytes; Humans; Insulin; Peptide Hydrolases; Prolyl Oligopeptidases; Serine Endopeptidases; Tuftsin; Tyrosine | 1986 |
The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling.
Topics: Angiotensin II; Humans; Inositol Phosphates; Models, Biological; Phosphorylation; Receptors, Angiotensin; Signal Transduction; Tyrosine | 1995 |
Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling.
Topics: Angiotensin II; Animals; Humans; Phosphorylation; Receptors, Angiotensin; Signal Transduction; Tyrosine | 1996 |
Angiotensin II-induced tyrosine phosphorylation in mesangial and vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Chloride Channels; Glomerular Mesangium; Muscle, Smooth, Vascular; Phosphorylation; Rats; Tyrosine | 1996 |
Signal transduction in vascular smooth muscle.
Topics: Angiotensin II; Animals; Humans; Muscle, Smooth, Vascular; Oxidation-Reduction; Phosphorylation; Receptors, Angiotensin; Signal Transduction; Tyrosine | 1996 |
Cross-talk between angiotensin II and interleukin-6-induced signaling through Stat3 transcription factor.
Topics: Angiotensin II; Animals; DNA-Binding Proteins; Humans; Interleukin-6; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Tyrosine | 1998 |
Angiotensin II signal transduction pathways.
Topics: Amino Acid Sequence; Angiotensin II; Cell Adhesion Molecules; Focal Adhesion Protein-Tyrosine Kinases; GTP-Binding Proteins; Molecular Sequence Data; Phosphorylation; Protein-Tyrosine Kinases; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction; Structure-Activity Relationship; Tyrosine | 1998 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance.
Topics: Angiotensin II; Cardiovascular Diseases; ErbB Receptors; Humans; Inflammation; Receptor, Angiotensin, Type 1; Tyrosine | 2023 |
2 trial(s) available for tyrosine and angiotensin ii
| Article | Year |
|---|---|
Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease.
Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Arterioles; Brimonidine Tartrate; Cold Temperature; Enzyme Inhibitors; Female; Genistein; Humans; Middle Aged; Phosphorylation; Protein-Tyrosine Kinases; Quinoxalines; Raynaud Disease; Serotonin; Signal Transduction; Skin; Skin Temperature; Tyrosine; Tyrphostins; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
234 other study(ies) available for tyrosine and angiotensin ii
| Article | Year |
|---|---|
Reaction of bovine and equine growth hormones with tetranitromethane.
Topics: Amino Acids; Angiotensin II; Animals; Cattle; Chromatography, Gel; Growth Hormone; Horses; Hydrogen-Ion Concentration; Methane; Molecular Weight; Species Specificity; Tetranitromethane; Time Factors; Tryptophan; Tyrosine; Urea | 1977 |
Effect of tyrosine ionization upon biological activities of angiotensin II and two new peptide analogues.
Topics: Angiotensin II; Animals; Biological Assay; Female; Guinea Pigs; Hydrogen-Ion Concentration; Ileum; Muscle Contraction; Rats; Structure-Activity Relationship; Tyrosine; Uterus | 1977 |
Interaction of the enantiomers of warfarin with human serum albumin, peptides and amino acids [proceedings].
Topics: Angiotensin II; Humans; In Vitro Techniques; Pentagastrin; Protein Binding; Stereoisomerism; Tryptophan; Tyrosine; Warfarin | 1977 |
Study on the influence of tyrosine deprotonation on the myotropic action of angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Hydrogen-Ion Concentration; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Rabbits; Structure-Activity Relationship; Tyrosine | 1979 |
Synthesis of angiotensin II analogues by incorporating beta-homotyrosine or beta-homoisoleucine residues.
Topics: Angiotensin II; Animals; Blood Pressure; Chymotrypsin; Isoleucine; Leucyl Aminopeptidase; Rats; Structure-Activity Relationship; Time Factors; Tyrosine | 1979 |
Radiolabeling of antigens: procedures and assessment of properties.
Topics: Angiotensin II; Antigens; Chloramines; Chorionic Gonadotropin; Chromatography, Gel; Digitoxigenin; Follicle Stimulating Hormone; Growth Hormone; Haptens; Iodine Radioisotopes; Isotope Labeling; Luteinizing Hormone; Parathyroid Hormone; Radioimmunoassay; Serum Albumin, Radio-Iodinated; Tyrosine | 1975 |
Angiotensin II stimulates two myelin basic protein/microtubule-associated protein 2 kinases in cultured vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Glycogen Synthase Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinases; Rats; Signal Transduction; Substrate Specificity; Tyrosine | 1992 |
Involvement of MAP kinase activators in angiotensin II-induced activation of MAP kinases in cultured vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Chromatography, DEAE-Cellulose; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinases; Rats; Serine; Threonine; Tyrosine | 1992 |
Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Enzyme Activation; Epidermal Growth Factor; In Vitro Techniques; Liver; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Time Factors; Tyrosine | 1992 |
Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Kinetics; Male; Molecular Weight; Muscle, Smooth, Vascular; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein Kinases; Rats; Rats, Sprague-Dawley; Tyrosine | 1992 |
Transient epidermal growth factor (EGF)-dependent suppression of EGF receptor autophosphorylation during internalization.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Line; Epidermal Growth Factor; Epithelium; ErbB Receptors; Kinetics; Liver; Phosphorylation; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Tetradecanoylphorbol Acetate; Tyrosine | 1990 |
Evidence that the epidermal growth factor receptor and non-tyrosine kinase hormone receptors stimulate phosphoinositide hydrolysis by independent pathways.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Cell Line; Epidermal Growth Factor; Epinephrine; Epithelium; ErbB Receptors; Guanosine Diphosphate; Guanylyl Imidodiphosphate; Hydrolysis; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Liver; Mice; Phosphotyrosine; Protein Kinase C; Rats; Receptors, Adrenergic, alpha; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Thionucleotides; Tyrosine | 1990 |
Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcimycin; Calcium; Cell Line; Epidermal Growth Factor; Ionomycin; Kinetics; Phosphorylation; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Terpenes; Thapsigargin; Tyrosine | 1990 |
Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells.
Topics: Alkaloids; Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Endothelins; Glomerular Mesangium; Phosphorylation; Phosphotyrosine; Protein Kinase C; Rats; Rats, Inbred Strains; Staurosporine; Substrate Specificity; Tyrosine; Vasopressins | 1991 |
Autophosphorylation of the intracellular domain of the epidermal growth factor receptor results in different effects on its tyrosine kinase activity with various peptide substrates. Phosphorylation of peptides representing Tyr(P) sites of phospholipase C-
Topics: Amino Acid Sequence; Angiotensin II; Cell Membrane; Epidermal Growth Factor; ErbB Receptors; Kinetics; Molecular Sequence Data; Peptides; Phosphorylation; Protein-Tyrosine Kinases; Substrate Specificity; Type C Phospholipases; Tyrosine | 1991 |
Characterization of angiotensin II (AT2) binding sites in R3T3 cells.
Topics: Angiotensin II; Animals; Binding Sites; Binding, Competitive; Bombesin; Cell Division; Cells, Cultured; Dithiothreitol; Iodine Radioisotopes; Mice; Second Messenger Systems; Tyrosine | 1991 |
Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.
Topics: Angiotensin II; Binding Sites; Kinetics; Protein Conformation; Receptors, Angiotensin; Spectrometry, Fluorescence; Structure-Activity Relationship; Time Factors; Tyrosine | 1991 |
Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cells, Cultured; Ionomycin; Muscle, Smooth, Vascular; Norepinephrine; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Serotonin; Tetradecanoylphorbol Acetate; Tyrosine; Vasoconstrictor Agents | 1991 |
Assay of tyrosine protein kinase activity from HL-60 by high-performance liquid chromatography for specificity studies.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Angiotensin II; Chromatography, High Pressure Liquid; Feasibility Studies; Humans; Molecular Sequence Data; Peptides; Phosphorylation; Protein-Tyrosine Kinases; Tyrosine | 1990 |
The influence of angiotensin II on catecholamine synthesis in neuronal cultures from rat brain.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Animals; Animals, Newborn; Brain Stem; Catecholamines; Cells, Cultured; Dopamine; Hypothalamus; Kinetics; Neurons; Norepinephrine; Rats; Rats, Inbred WKY; Tyrosine | 1990 |
Pharmacological activity of angiotensin-II modified by tyrosine sulfation.
Topics: Angiotensin II; Animals; Arylsulfotransferase; Gallbladder; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Rats; Sulfates; Tyrosine | 1990 |
The insulin-like growth factor II receptor is phosphorylated by a tyrosine kinase in adipocyte plasma membranes.
Topics: Adenosine Triphosphate; Adipose Tissue; Angiotensin II; Animals; Cell Membrane; Insulin-Like Growth Factor II; Kinetics; Male; Molecular Weight; Phosphorus Radioisotopes; Phosphotyrosine; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Somatomedin; Somatomedins; Tyrosine | 1986 |
The nuclear matrix from rat liver is capable of phosphorylating exogenous tyrosine-containing substrates.
Topics: Adenosine Triphosphate; Amino Acids; Angiotensin II; Animals; Catalysis; Cell Nucleus; Genistein; Isoflavones; Kinetics; Liver; Magnesium; Manganese; Phosphorylation; Protein-Tyrosine Kinases; Rats; Tyrosine | 1989 |
Phosphorylation of protein tyrosine by human erythrocyte casein kinase A.
Topics: Angiotensin II; Ankyrins; Casein Kinases; Erythrocytes; Humans; Isoenzymes; Membrane Proteins; Peptides; Phosphorylation; Protein Kinases; Serine; Threonine; Tyrosine | 1986 |
Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
Topics: Abelson murine leukemia virus; Adenosine Triphosphate; Angiotensin II; Cell Transformation, Viral; DNA, Viral; Edetic Acid; Escherichia coli; Kinetics; Leukemia Virus, Murine; Magnesium; Manganese; Molecular Weight; Osmolar Concentration; Phosphorylation; Protein Kinases; Protein-Tyrosine Kinases; Tyrosine | 1985 |
Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain.
Topics: Angiotensin II; Angiotensin III; Animals; Brain; Chromatography, High Pressure Liquid; Male; Membranes; Peptide Fragments; Peptide Hydrolases; Rats; Rats, Inbred Strains; Substrate Specificity; Tyrosine | 1988 |
Tyrosine in position 4 is the key amino acid for the binding of angiotensin II to human arteriolar receptor.
Topics: Adult; Angiotensin II; Arterioles; Blood Pressure; Humans; Male; Peptide Fragments; Receptors, Angiotensin; Tyrosine | 1987 |
Proteolytic activity of largomycin.
Topics: Aminoglycosides; Angiotensin II; Anti-Bacterial Agents; Arginine; Cell Line; Glycoproteins; Humans; Membrane Proteins; Molecular Weight; Peptide Hydrolases; Substrate Specificity; Tyrosine | 1985 |
Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Female; In Vitro Techniques; Phenylalanine; Protein Conformation; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Structure-Activity Relationship; Tryptophan; Tyrosine; Uterus | 1985 |
Kinetics of acetylation-deacetylation of angiotensin II. Intramolecular interactions of the tyrosine and histidine side-chains.
Topics: Acetic Anhydrides; Acetylation; Angiotensin II; Chemical Phenomena; Chemistry; Dealkylation; Histidine; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Nitrophenols; Protein Conformation; Spectrophotometry, Infrared; Tyrosine | 1985 |
The specific cleavage of tyrosyl-peptide bonds by electrolytic oxidation.
Topics: Angiotensin II; Chemical Phenomena; Chemistry; Electrolysis; Glycine; Insulin; Ketones; Peptides; Spironolactone; Tyrosine | 1966 |
Synthesis of isoleucine-5-tyrosine-8-angiotensin II and isoleucine-5-hydroxyproline-7-angiotensin II.
Topics: Angiotensin II; Chemistry, Organic; Hydroxyproline; Isoleucine; Organic Chemistry Phenomena; Peptides; Tyrosine | 1966 |
The action of trypsin and of chymotrypsin on phenylthiocarbamyl-angiotensin II.
Topics: Angiotensin II; Animals; Arginine; Asparagine; Blood Pressure; Chemical Phenomena; Chemistry; Chromatography, Paper; Chymotrypsin; Dogs; Electrophoresis; Sulfur Isotopes; Trypsin; Tyrosine; Valine | 1967 |
Conformation studies with polypeptides by rotatory dispersion and thin-film dialysis.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Bacitracin; Dialysis; Optical Rotatory Dispersion; Peptides; Piperazines; Polymyxins; Tyrosine; Tyrothricin | 1968 |
Fluorescence and protein structure. XIV. Tyrosine fluorescence in helical muscle proteins.
Topics: Angiotensin II; Animals; Aspartic Acid; Electrophoresis, Disc; Fluorescence; Glutamates; Hot Temperature; Hydrogen-Ion Concentration; Iodine; Models, Chemical; Molecular Weight; Mollusca; Muscle Proteins; Muscles; Peptide Hydrolases; Protein Denaturation; Rabbits; Ribonucleases; Spectrophotometry; Spectrum Analysis; Trypsin; Tyrosine | 1968 |
Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues.
Topics: Angiotensin II; Animals; Carbon Isotopes; Chromatography; Guinea Pigs; Heart; Heart Atria; Male; Norepinephrine; Rats; Tyrosine; Vas Deferens | 1969 |
Changes in the short wavelength absorption spectrum of tyrosine as a result of its participation in peptide, or similar bonds.
Topics: Angiotensin II; Carboxypeptidases; Chemical Phenomena; Chemistry; Chymotrypsin; Peptides; Spectrophotometry; Tyrosine; Ultraviolet Rays | 1969 |
Purification and properties of endopeptidase from rabbit red cells and its process of degradation of angiotensin.
Topics: Amides; Amidohydrolases; Amino Acids; Angiotensin II; Animals; Biological Assay; Blood Pressure; Caseins; Chemical Precipitation; Chromatography, DEAE-Cellulose; Chromatography, Gel; Chromatography, Thin Layer; Electrophoresis; Endopeptidases; Erythrocytes; Esterases; Esters; Methods; Peptide Hydrolases; Quaternary Ammonium Compounds; Rabbits; Rats; Sulfonic Acids; Toluene; Tyrosine; Vagotomy | 1969 |
Analogs of angiotensin II. I. Solid phase synthesis.
Topics: Amino Acids; Angiotensin II; Blood Pressure; Chromatography, Paper; Electrophoresis; Methods; Peptides; Tyrosine | 1970 |
A proposed structure and active site of angiotensin.
Topics: Amino Acid Sequence; Angiotensin II; Binding Sites; Chemical Phenomena; Chemistry; Histidine; Models, Structural; Tyrosine | 1970 |
Effect of angiotensin on noradrenaline-3H accumulation and synthesis in vivo.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Catecholamines; Desipramine; Drug Synergism; Female; Myocardium; Norepinephrine; Ouabain; Rats; Spleen; Sympathetic Nervous System; Synaptic Transmission; Tritium; Tyrosine | 1971 |
Inactivation studies of angiotensin II by purified enzymes.
Topics: Amino Acids; Aminopeptidases; Angiotensin II; Animals; Arginine; Aspartic Acid; Brain; Isoleucine; Naphthalenes; Peptide Hydrolases; Swine; Tyrosine; Valine | 1971 |
Hepatic origin of renin substrate.
Topics: Angiotensin II; Animals; Carbon Isotopes; Female; Kinetics; Liver; Nephrectomy; Puromycin; Rats; Rats, Inbred Strains; Renin; Tyrosine | 1971 |
Isolation and some properties of cathepsin A from bovine spleen.
Topics: Angiotensin II; Animals; Catalysis; Cathepsins; Cattle; Chemical Precipitation; Chromatography, Gel; Chromatography, Ion Exchange; Chromatography, Thin Layer; Electrophoresis, Disc; Ethanol; Isoflurophate; Methylene Blue; Radiation Effects; Spleen; Structure-Activity Relationship; Tosyl Compounds; Tyrosine; Ultraviolet Rays; Valine | 1972 |
Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
Topics: Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Cats; Chromatography, Thin Layer; Electrophoresis, Paper; Female; Histidine; In Vitro Techniques; Isoleucine; Muscle Contraction; Rabbits; Rats; Structure-Activity Relationship; Tyrosine; Uterus | 1972 |
Studies on angiotensinogen formation in a liver perfusion system.
Topics: Adrenal Glands; Adrenalectomy; Angiotensin II; Animals; Carbon Isotopes; Chlorides; Diethylstilbestrol; Female; Hepatectomy; Isoleucine; Kidney; Liver; Mercury; Nephrectomy; Perfusion; Protein Biosynthesis; Puromycin; Rats; Renin; Tyrosine; Ureter | 1972 |
Angiotensin-receptor interaction: influence of pH on angiotensin inhibition by Phe 4 -Tyr 8 -angiotensin II in rat uterine smooth muscle.
Topics: Angiotensin II; Animals; Binding Sites; Buffers; Female; Hydrogen-Ion Concentration; Muscle Contraction; Muscle, Smooth; Phenylalanine; Rats; Receptors, Drug; Tyrosine; Uterus | 1972 |
Acceleration of protein synthesis by angiotensin--correlation with angiotensin's effect on catecholamine biosynthesis.
Topics: Angiotensin II; Animals; Carbon Isotopes; Catecholamines; Cycloheximide; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; In Vitro Techniques; Leucine; Male; Muscle Proteins; Neurons; Norepinephrine; Puromycin; Spleen; Tritium; Tyrosine | 1972 |
Acceleration of catecholamine biosynthesis in sympathetically innervated tissues by angiotensin-II-amide..
Topics: Angiotensin II; Animals; Carbon Isotopes; Catecholamines; Chromatography; Dihydroxyphenylalanine; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Norepinephrine; Portal Vein; Rabbits; Rats; Sympathetic Nervous System; Time Factors; Tyrosine; Vas Deferens; Vasopressins | 1972 |
Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine.
Topics: Angiotensin II; Animals; Blood Pressure; Cerebral Ventricles; Chlorides; Dihydroxyphenylalanine; Dopamine; Electrocardiography; Electrodes; Esters; Hydrogen-Ion Concentration; Male; Nerve Crush; Norepinephrine; Rats; Sympathetic Nervous System; Tyrosine | 1973 |
Conformational studies of angiotensin peptides in aqueous solution by proton magnetic resonance.
Topics: Angiotensin II; Deuterium; Half-Life; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Peptides; Protein Conformation; Temperature; Tyrosine; Valine | 1973 |
Structural requirements for substrates and inhibitors of angiotensin I-converting enzyme in vivo and vitro.
Topics: Amino Acids; Aminopeptidases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoanalysis; Biological Assay; Chromatography, Ion Exchange; Chymotrypsin; Dogs; Electrophoresis, Paper; Heparin; Humans; Hydrolysis; In Vitro Techniques; Iodine Radioisotopes; Methods; Pulmonary Circulation; Trypsin; Tyrosine | 1974 |
Stimulation by angiotensin of myocardial prostaglandin synthesis.
Topics: Angiotensin II; Animals; Enzyme Activation; Heart; Hydroxydopamines; In Vitro Techniques; Male; Mixed Function Oxygenases; Myocardium; Norepinephrine; Propranolol; Prostaglandins; Rats; Stimulation, Chemical; Time Factors; Tyrosine | 1974 |
Interaction of angiotensin peptides and of amino acids with p-nitrophenyl acetate.
Topics: Acetates; Amino Acid Sequence; Amino Acids; Angiotensin II; Chemical Phenomena; Chemistry; Histidine; Hydrogen-Ion Concentration; Imidazoles; Kinetics; Mathematics; Nitrobenzenes; Peptides; Phenols; Phenyl Ethers; Structure-Activity Relationship; Tyrosine | 1974 |
Angiotensin and biosynthesis of norepinephrine.
Topics: Angiotensin II; Animals; Axons; Chromatography, Ion Exchange; Depression, Chemical; Desipramine; Dihydroxyphenylalanine; Heart Atria; In Vitro Techniques; Myocardium; Norepinephrine; Ouabain; Rats; Receptors, Adrenergic; Stimulation, Chemical; Trichloroacetic Acid; Tritium; Tyrosine; Tyrosine 3-Monooxygenase | 1971 |
Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain.
Topics: Adrenal Cortex; Amino Acid Sequence; Angiotensin II; Animals; Aorta; Blood Pressure; Cattle; Rabbits; Rats; Structure-Activity Relationship; Tyrosine | 1984 |
Laser raman spectroscopic analysis of angiotensin peptides' conformation.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Hydrogen Bonding; Protein Conformation; Saralasin; Spectrum Analysis, Raman; Tyrosine | 1980 |
Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Benzoquinones; Calcium-Calmodulin-Dependent Protein Kinases; Cattle; Cell Division; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Genes, fos; Genistein; Isoflavones; Lactams, Macrocyclic; Male; Muscle Proteins; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Inbred BN; Receptors, Angiotensin; Rifabutin; RNA, Messenger; Stimulation, Chemical; Tetradecanoylphorbol Acetate; Transcriptional Activation; Type C Phospholipases; Tyrosine | 1995 |
Angiotensin II mediates intracellular signalling in vascular smooth muscle cells by activation of tyrosine-specific protein kinases and c-raf-1.
Topics: Angiotensin II; Animals; Aorta; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Kinetics; Molecular Weight; Muscle, Smooth, Vascular; Phosphoproteins; Phosphotyrosine; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Signal Transduction; Time Factors; Tyrosine | 1993 |
Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2.
Topics: Adrenal Gland Neoplasms; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cell Membrane; Chromatography, Affinity; Guanosine Diphosphate; Imidazoles; Losartan; Oligopeptides; PC12 Cells; Pertussis Toxin; Pheochromocytoma; Phosphates; Phosphoproteins; Phosphorus Radioisotopes; Phosphotyrosine; Protein Tyrosine Phosphatases; Pyridines; Rats; Receptors, Angiotensin; Tetrazoles; Thionucleotides; Tyrosine; Virulence Factors, Bordetella | 1994 |
Dephosphorylation of phosphopeptides by calcineurin (protein phosphatase 2B).
Topics: Amino Acid Sequence; Angiotensin II; Animals; Calcineurin; Calmodulin-Binding Proteins; Casein Kinases; Kinetics; Liver; Molecular Sequence Data; Phosphopeptides; Phosphoprotein Phosphatases; Phosphoserine; Phosphotyrosine; Protein Kinases; Rats; Substrate Specificity; Tyrosine | 1994 |
Synergistic activation of tyrosine phosphorylation by o-vanadate plus calcium ionophore A23187 or aromatic 1,2-diols.
Topics: Acetylcysteine; Angiotensin II; Animals; Calcimycin; Cell Line; Cell Line, Transformed; Drug Synergism; Egtazic Acid; Enzyme Activation; Flavonoids; Flavonols; Indomethacin; Liver; Masoprocol; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Quercetin; Rats; Tyrosine; Vanadates | 1994 |
Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Topics: 3T3 Cells; Angiotensin II; Animals; Antibodies; Aorta; Becaplermin; Cell Division; Culture Media, Conditioned; DNA; Dose-Response Relationship, Drug; Genes, fos; Growth Substances; Kinetics; Mice; Mitogens; Muscle, Smooth, Vascular; Phosphoproteins; Phosphotyrosine; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Suramin; Thymidine; Tyrosine | 1994 |
Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase.
Topics: Angiotensin II; Animals; Caffeine; Calcium; Cell Cycle; Cells, Cultured; Cytosol; Genistein; Isoflavones; Male; Muscle, Smooth, Vascular; Nitriles; Phosphotyrosine; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Ryanodine; Second Messenger Systems; Signal Transduction; Tyrosine | 1994 |
The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases.
Topics: Angiotensin II; Animals; Aorta; Cells, Cultured; Cloning, Molecular; Genes, src; Glutathione Transferase; Isoenzymes; Kinetics; Muscle, Smooth, Vascular; Phosphates; Phosphorus Radioisotopes; Phosphorylation; Phosphoserine; Phosphotyrosine; Rats; Receptor Protein-Tyrosine Kinases; Receptors, Angiotensin; Recombinant Fusion Proteins; Substrate Specificity; Type C Phospholipases; Tyrosine | 1994 |
Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II.
Topics: Angiotensin II; Animals; Cell Adhesion Molecules; Embryonic and Fetal Development; Enzyme Induction; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Muscle, Smooth, Vascular; Phosphotyrosine; Protein-Tyrosine Kinases; Time Factors; Tyrosine | 1994 |
Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein.
Topics: Angiotensin II; Animals; Animals, Newborn; Base Sequence; Cells, Cultured; DNA-Binding Proteins; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Losartan; Molecular Sequence Data; Myocardium; Nuclear Proteins; Phosphotyrosine; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; Tetrazoles; Trans-Activators; Transcription Factors; Transcription, Genetic; Tyrosine | 1994 |
Regulation of vascular and gastric smooth muscle contractility by pervanadate.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blotting, Western; Calcium; Epidermal Growth Factor; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Sodium; Stomach; Tyrosine; Vanadates | 1994 |
Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Biphenyl Compounds; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Imidazoles; Kinetics; Losartan; Male; Molecular Weight; Muscle, Smooth, Vascular; Phosphoproteins; Phosphorylation; Phosphoserine; Phosphothreonine; Phosphotyrosine; Polyenes; Protein Biosynthesis; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred BN; Receptors, Angiotensin; Ribosomal Protein S6 Kinases; Sirolimus; Tetrazoles; Tyrosine | 1995 |
Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Becaplermin; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cytoskeletal Proteins; Endothelins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Kinetics; Muscle, Smooth, Vascular; Paxillin; Phosphoproteins; Phosphorylation; Phosphotyrosine; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Rats; Receptor, Insulin; Recombinant Proteins; Stress, Mechanical; Tetradecanoylphorbol Acetate; Thrombin; Tyrosine | 1995 |
Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Antibodies; Aorta; Cells, Cultured; Electroporation; Flow Cytometry; Inositol 1,4,5-Trisphosphate; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Proto-Oncogene Proteins pp60(c-src); Rats; Type C Phospholipases; Tyrosine | 1995 |
Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart.
Topics: Angiotensin II; Animals; Electrophoresis, Polyacrylamide Gel; Immunoblotting; In Vitro Techniques; Insulin; Insulin Receptor Substrate Proteins; Male; Molecular Weight; Myocardium; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Phosphotyrosine; Rats; Tyrosine | 1995 |
Contrasting mechanisms of intracellular calcium ([Ca2+]i) elevation by angiotensin II (AII) and platelet derived growth factor-BB (PDGF-BB) in human vascular smooth muscle cells (VSMCs).
Topics: Angiotensin II; Becaplermin; Calcium; Cells, Cultured; Humans; Kinetics; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Recombinant Proteins; Saphenous Vein; Tyrosine | 1995 |
Sustained effect of angiotensin II on tyrosine phosphorylation of annexin I in glomerular mesangial cells.
Topics: Angiotensin II; Animals; Annexin A1; Calcium; Cells, Cultured; Chromatography, Affinity; Egtazic Acid; Electrophoresis, Polyacrylamide Gel; Glomerular Mesangium; Male; Molecular Weight; Phosphates; Phospholipids; Phosphoproteins; Phosphorus Radioisotopes; Phosphorylation; Phosphotyrosine; Rats; Rats, Wistar; Tyrosine | 1993 |
Cyclic peptide substrates of pp60c-src. Synthesis and evaluation.
Topics: Amino Acid Sequence; Angiotensin II; Kinetics; Molecular Sequence Data; Peptides, Cyclic; Protein Conformation; Proto-Oncogene Proteins pp60(c-src); Structure-Activity Relationship; Substrate Specificity; Tyrosine; Valine | 1993 |
Critical role of a conserved intramembrane tyrosine residue in angiotensin II receptor activation.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cell Line; Cell Membrane; Conserved Sequence; Endocytosis; Molecular Sequence Data; Rats; Receptors, Angiotensin; Signal Transduction; Tyrosine | 1995 |
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.
Topics: Angiotensin II; Animals; Aorta; Cell Line; DNA-Binding Proteins; Enzyme Activation; Epidermal Growth Factor; Humans; Interferon-gamma; Janus Kinase 2; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptors, Angiotensin; STAT1 Transcription Factor; STAT2 Transcription Factor; Trans-Activators; Tyrosine | 1995 |
Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Cell Adhesion Molecules; Cytoskeletal Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Male; Muscle, Smooth, Vascular; Paxillin; Phosphoproteins; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Rats; Receptors, Angiotensin; Tyrosine | 1995 |
Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling.
Topics: Angiotensin II; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Genes, fos; GTP-Binding Proteins; Myocardium; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Ribosomal Protein S6 Kinases; Tetradecanoylphorbol Acetate; Tyrosine | 1995 |
Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts.
Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Angiotensin II; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion Molecules; Cells, Cultured; Fibroblasts; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; GTP-Binding Proteins; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; Phorbol Esters; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Protein-Tyrosine Kinases; Proteins; Rats; Rats, Sprague-Dawley; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; Tyrosine | 1994 |
Effect of angiotensin II on human vascular smooth muscle cell growth.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Humans; Hypertrophy; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; Species Specificity; Tyrosine | 1994 |
Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor.
Topics: Angiotensin II; Animals; Autoradiography; Cells, Cultured; Colforsin; Immunoblotting; Ionomycin; Male; Muscle, Smooth, Vascular; Phosphorylation; Precipitin Tests; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Serine; Tetradecanoylphorbol Acetate; Tyrosine | 1994 |
Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cells, Cultured; Isoenzymes; Kinetics; Muscle, Smooth, Vascular; Phospholipase C gamma; Phosphorylation; Platelet-Derived Growth Factor; Rats; Type C Phospholipases; Tyrosine | 1994 |
Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cells, Cultured; Enzyme Activation; Muscle, Smooth, Vascular; Phosphorylation; Precipitin Tests; Protein Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Tyrosine | 1993 |
Tyrosine phosphorylation, MAPK and PLD in AII stimulated mitogenesis.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Activation; Enzyme Inhibitors; Genistein; Isoflavones; Mitosis; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligopeptides; Phospholipase D; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Substrate Specificity; Tyrosine | 1995 |
Characterization of radiation-induced thymine-tyrosine crosslinks by electrospray ionization mass spectrometry.
Topics: Amino Acid Sequence; Angiotensin II; Cross-Linking Reagents; DNA; Mass Spectrometry; Molecular Sequence Data; Oligopeptides; Proteins; Thymine; Tyrosine | 1996 |
Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein.
Topics: Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Cytosol; Heart Ventricles; Hypertension; Molecular Weight; Muscle Proteins; Muscle, Skeletal; Myocardium; Phosphorylation; Phosphotyrosine; Precipitin Tests; Rats; Rats, Mutant Strains; Sodium Chloride, Dietary; Tyrosine | 1996 |
The role of protein kinase C in activation and termination of mitogen-activated protein kinase activity in angiotensin II-stimulated rat aortic smooth-muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle Proteins; Cells, Cultured; Colforsin; Cycloheximide; Dual Specificity Phosphatase 1; Enzyme Activation; Enzyme Inhibitors; Immediate-Early Proteins; Immunoblotting; Indoles; Isoenzymes; Mitogens; Muscle, Smooth, Vascular; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase C; Protein Phosphatase 1; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatases; Rats; Rats, Wistar; Signal Transduction; Tyrosine; Vasoconstrictor Agents | 1996 |
ANG II-induced tyrosine phosphorylation stimulates phospholipase C-gamma 1 and Cl-channels in mesangial cells.
Topics: Angiotensin II; Animals; Calcium; Chloride Channels; Glomerular Mesangium; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Isoenzymes; Male; Phospholipase C gamma; Phosphorylation; Rats; Rats, Sprague-Dawley; Type C Phospholipases; Tyrosine | 1996 |
Amino acid analysis by reverse-phase high-performance liquid chromatography: improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate.
Topics: Amino Acids; Angiotensin II; Chromatography, High Pressure Liquid; Fluorenes; Histidine; Humans; Indicators and Reagents; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 1996 |
Cross-talk between the insulin and angiotensin signaling systems.
Topics: Angiotensin II; Animals; Electrophoresis, Polyacrylamide Gel; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Male; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Tyrosine | 1996 |
The peroxynitrite product 3-nitro-L-tyrosine attenuates the hemodynamic responses to angiotensin II in vivo.
Topics: Anesthesia; Angiotensin II; Animals; Hemodynamics; Male; Nitrates; Pentobarbital; Rats; Rats, Sprague-Dawley; Tyrosine; Vasoconstrictor Agents | 1996 |
Angiotensin II signaling in vascular smooth muscle. New concepts.
Topics: Angiotensin II; Calcium-Calmodulin-Dependent Protein Kinases; Down-Regulation; Enzyme Activation; Humans; Muscle, Smooth, Vascular; Phosphorylation; Signal Transduction; Type C Phospholipases; Tyrosine | 1997 |
Role of intracellular calcium in the angiotensin II-mediated tyrosine phosphorylation and dephosphorylation of PLC-gamma 1.
Topics: Angiotensin II; Animals; Aorta; Calcium; Cells, Cultured; Chelating Agents; Egtazic Acid; Inositol 1,4,5-Trisphosphate; Intracellular Fluid; Ionomycin; Isoenzymes; Muscle, Smooth, Vascular; Phospholipase C gamma; Phosphorylation; Rats; Type C Phospholipases; Tyrosine | 1997 |
Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Antibodies; Electroporation; Enzyme Activation; Insulin Receptor Substrate Proteins; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Macromolecular Substances; Male; Muscle, Smooth, Vascular; Phosphoproteins; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Tyrosine | 1997 |
Profiling peptide adducts of oxidized N-acetyldopamine by electrospray mass spectrometry.
Topics: Angiotensin II; Dopamine; Mass Spectrometry; Oxidation-Reduction; Peptides; Tyrosine | 1997 |
A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Arsenicals; Binding Sites; Cell Line; Cricetinae; Cricetulus; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; GRB2 Adaptor Protein; Immunosorbent Techniques; Isoenzymes; Phospholipase C gamma; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Rats; Recombinant Fusion Proteins; Sulfhydryl Compounds; Type C Phospholipases; Tyrosine | 1997 |
Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Binding Sites; COS Cells; Enzyme Inhibitors; Janus Kinase 2; Molecular Sequence Data; Nitriles; Peptide Fragments; Phosphorylation; Protein Binding; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; Signal Transduction; Transfection; Tyrosine; Tyrphostins | 1997 |
The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; DNA-Binding Proteins; Heart; Imidazoles; Janus Kinase 2; Losartan; Myocardium; Nitriles; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrosine; Tyrphostins | 1997 |
Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma-associated proteins. Characterization of a c-Src-dependent 97-kD protein in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cells, Cultured; Genes, src; Isoenzymes; Male; Mice; Mice, Knockout; Molecular Weight; Muscle, Smooth, Vascular; Peptide Fragments; Phosphorylation; Precipitin Tests; Rats; Rats, Sprague-Dawley; src-Family Kinases; Type C Phospholipases; Tyrosine | 1997 |
Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.
Topics: Amlodipine; Angioplasty, Balloon; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Carotid Artery Injuries; Carotid Artery, Common; ErbB Receptors; Insulin Receptor Substrate Proteins; Male; Phosphoproteins; Phosphorylation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Receptors, Angiotensin; Receptors, Platelet-Derived Growth Factor; Tetrazoles; Tunica Intima; Tyrosine | 1997 |
Divergence in the G-protein-coupled receptor mitogenic signalling pathway at the level of Raf kinase.
Topics: 3T3 Cells; Angiotensin II; Animals; Cell Division; Enzyme Activation; GTP-Binding Proteins; Mice; Mitogens; Phosphorylation; Proto-Oncogene Proteins c-raf; Signal Transduction; Substrate Specificity; Thrombin; Tyrosine; Vasoconstrictor Agents | 1997 |
Stimulation of 42/44 kDa mitogen-activated protein kinases by arginine vasopressin in rat cardiomyocytes.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Myelin Basic Protein; Myocardium; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Rats; Receptors, Vasopressin; Signal Transduction; Tetradecanoylphorbol Acetate; Threonine; Tyrosine; Vasoconstrictor Agents | 1998 |
Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomegaly; Cells, Cultured; Interferon-gamma; Interferons; Janus Kinase 2; Myocardium; Phosphorylation; Phosphotransferases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Wistar; Signal Transduction; Stereoisomerism; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
Tyrosine phosphorylation and association of p130Cas and c-Crk II by ANG II in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Crk-Associated Substrate Protein; Kinetics; Muscle, Smooth, Vascular; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-crk; Rats; Receptors, Angiotensin; Retinoblastoma-Like Protein p130; Tyrosine; Virulence Factors, Bordetella | 1998 |
Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Heart Ventricles; Janus Kinase 2; Milk Proteins; Molecular Sequence Data; Myocardium; Nitriles; Phosphorylation; Prolactin; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; STAT5 Transcription Factor; Trans-Activators; Tyrosine; Tyrphostins | 1998 |
Phosphorylation of p130Cas by angiotensin II is dependent on c-Src, intracellular Ca2+, and protein kinase C.
Topics: 3T3 Cells; Angiotensin II; Animals; Calcium; Cells, Cultured; Crk-Associated Substrate Protein; Cytochalasin D; Male; Mice; Phosphoproteins; Phosphorylation; Protein Kinase C; Proteins; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Sprague-Dawley; Retinoblastoma-Like Protein p130; Signal Transduction; Sodium Fluoride; Tyrosine | 1998 |
Janus kinase 2 (Jak2) must be catalytically active to associate with the AT1 receptor in response to angiotensin II.
Topics: Angiotensin II; Animals; Binding Sites; Chlorocebus aethiops; COS Cells; Enzyme Activation; Janus Kinase 2; Ligands; Macromolecular Substances; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; Transfection; Tyrosine | 1998 |
Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle.
Topics: Actins; Angiotensin II; Animals; Anti-Arrhythmia Agents; Aorta; Calcium; Cell Adhesion Molecules; Cells, Cultured; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Focal Adhesion Protein-Tyrosine Kinases; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Insulin; Receptors, Angiotensin; src-Family Kinases; Tyrosine | 1998 |
Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1.
Topics: Angiotensin II; Animals; Cell Cycle Proteins; DNA-Binding Proteins; Dual Specificity Phosphatase 1; Immediate-Early Proteins; Janus Kinase 2; Male; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; Trans-Activators; Tyrosine | 1998 |
Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cytoprotection; DNA-Binding Proteins; Dose-Response Relationship, Drug; Growth Inhibitors; Heart Ventricles; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Mice; Myocardium; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor; Tetrazoles; Trans-Activators; Tyrosine | 1998 |
EGF-stimulated aldosterone secretion is mediated by tyrosine phosphorylation but not by phospholipase C in cultured porcine adrenal glomerulosa cells.
Topics: Aldosterone; Angiotensin II; Animals; Cells, Cultured; Epidermal Growth Factor; Inositol Phosphates; Phosphorylation; Signal Transduction; Stimulation, Chemical; Swine; Type C Phospholipases; Tyrosine; Zona Glomerulosa | 1998 |
Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Space; Flavonoids; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Receptors, Angiotensin; Tyrosine; Tyrphostins; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor.
Topics: Angiotensin I; Angiotensin II; Animals; COS Cells; Phenylalanine; Receptors, Angiotensin; Tyrosine | 1999 |
Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
Topics: Angiotensin II; Animals; Cell Line; Cell Membrane; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; ErbB Receptors; Humans; Ligands; Mice; Peptide Fragments; Phosphorylation; Polylysine; Protein-Tyrosine Kinases; Threonine; Tyrosine | 1999 |
Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase.
Topics: Angiotensin II; Animals; Carbon Radioisotopes; Cattle; Coronary Vasospasm; Coronary Vessels; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dinoprostone; Epoprostenol; Immunohistochemistry; In Vitro Techniques; Intramolecular Oxidoreductases; Nitrates; Oxidants; Potassium Chloride; Prostaglandin Antagonists; Prostaglandin H2; Prostaglandins; Prostaglandins H; Proteins; Tyrosine; Vasoconstriction; Vasodilation | 1999 |
Amplification of angiotensin II signaling in cardiac myocytes by adenovirus-mediated overexpression of the AT1 receptor.
Topics: Adenoviridae; Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Activation; Myocardium; Phosphorylation; Proteins; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Tyrosine | 1999 |
Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bridged Bicyclo Compounds, Heterocyclic; Cattle; Coronary Vasospasm; Cytochrome P-450 Enzyme System; Fatty Acids, Unsaturated; Hydrazines; Hypoxia; In Vitro Techniques; Indomethacin; Intramolecular Oxidoreductases; Nitrates; Oxygen; Tyrosine | 1999 |
Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation.
Topics: Angiotensin II; Collagen; Enzyme Inhibitors; Fibrinogen; Genistein; Humans; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinases; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transforming Growth Factor beta; Tyrosine; Tyrphostins | 1999 |
Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cell Division; Cells, Cultured; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Tyrosine | 1999 |
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cardiovascular Diseases; Endothelium, Vascular; Hemodynamics; Image Processing, Computer-Assisted; Immunohistochemistry; In Vitro Techniques; Male; Nitrates; Nitroprusside; Phenylephrine; Potassium Chloride; Rats; Rats, Sprague-Dawley; Renin; Tyrosine; Vasoconstriction | 2000 |
Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Topics: Angiotensin II; Animals; Endothelium, Vascular; Focal Adhesion Kinase 2; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-yes; Pulmonary Veins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; SH2 Domain-Containing Protein Tyrosine Phosphatases; Signal Transduction; src-Family Kinases; Tyrosine | 2000 |
Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor.
Topics: Amino Acid Substitution; Angiotensin II; Animals; CHO Cells; COS Cells; Cricetinae; DNA-Binding Proteins; Janus Kinase 2; Kinetics; Mutagenesis, Site-Directed; Phosphorylation; Protein Structure, Secondary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; Signal Transduction; STAT1 Transcription Factor; Trans-Activators; Transfection; Tyrosine | 2000 |
Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Antihypertensive Agents; Diabetes Mellitus, Type 1; Epoprostenol; Female; Fetus; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitroglycerin; Oxidative Stress; Placenta; Pre-Eclampsia; Pregnancy; Reactive Oxygen Species; Tyrosine; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Differentiation; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myelin Basic Protein; Nerve Growth Factor; Neurites; Neurons; PC12 Cells; Phosphorylation; Precipitin Tests; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tyrosine; Vasoconstrictor Agents | 2000 |
Inhibitors of tyrosine phosphatases block angiotensin II inhibition of Na(+) pump.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arsenicals; Enzyme Inhibitors; Female; Naphthalenes; Phospholipases A; Phosphorylation; Protein Kinase C; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Staurosporine; Tetramisole; Tyrosine | 2000 |
Endothelins increase tyrosine phosphorylation of astrocytic focal adhesion kinase and paxillin accompanied by their association with cytoskeletal components.
Topics: Androstadienes; Angiotensin II; Animals; Animals, Newborn; Astrocytes; Bradykinin; Bucladesine; Cerebral Cortex; Chelating Agents; Cytochalasin B; Cytoskeletal Proteins; Cytoskeleton; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; Enzyme Inhibitors; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Paxillin; Pertussis Toxin; Phosphoproteins; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Receptors, Endothelin; Tetradecanoylphorbol Acetate; Tyrosine; Vanadates; Virulence Factors, Bordetella; Wortmannin | 2000 |
Myocardial cell death in human diabetes.
Topics: Angiotensin II; Apoptosis; Cardiomegaly; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Tyrosine | 2000 |
The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR.
Topics: Amino Acid Motifs; Amino Acid Sequence; Amino Acids; Angiotensin II; Animals; Blotting, Western; Cell Nucleus; COS Cells; DNA-Binding Proteins; Gene Deletion; Janus Kinase 2; Luciferases; Molecular Sequence Data; Phosphorylation; Plasmids; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Signal Transduction; STAT1 Transcription Factor; Time Factors; Trans-Activators; Transcription, Genetic; Transfection; Tyrosine; Vaccinia virus | 2001 |
Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors.
Topics: Adrenal Medulla; Angiotensin II; Animals; Binding Sites; Cattle; Cell Nucleus; Cells, Cultured; Deoxyribonuclease I; DNA Footprinting; Fibroblast Growth Factor 2; Gene Expression Regulation; Imidazoles; Promoter Regions, Genetic; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; Response Elements; Signal Transduction; Trans-Activators; Tyrosine | 2001 |
Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cells, Cultured; CHO Cells; Cricetinae; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Oncogene Proteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein Transport; rac1 GTP-Binding Protein; Rats; Rats, Inbred WKY; Thymidine; Tyrosine | 2001 |
Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Angiotensin II; Animals; Antioxidants; Azoles; ErbB Receptors; Isoindoles; Male; Muscle, Smooth, Vascular; Onium Compounds; Organoselenium Compounds; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, ErbB-2; Transcriptional Activation; Tyrosine | 2001 |
Tyrosine kinase activation by the angiotensin II receptor in the absence of calcium signaling.
Topics: Adenosine Triphosphate; Amino Acid Substitution; Angiotensin II; Animals; Calcium; Calcium Signaling; Cell Line; CHO Cells; Cricetinae; DNA-Binding Proteins; Enzyme Activation; Fibroblasts; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Phosphotyrosine; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; STAT1 Transcription Factor; Trans-Activators; Transfection; Tyrosine | 2001 |
Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Blood Vessels; Body Weight; Genotype; Hypertrophy; Immunohistochemistry; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; RNA, Messenger; Superoxides; Tyrosine | 2001 |
Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells.
Topics: Angiotensin II; Animals; Binding, Competitive; Calcium; Cyclic AMP; Cyclic GMP; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Focal Adhesion Protein-Tyrosine Kinases; Iodine Radioisotopes; Kidney Tubules, Proximal; LLC-PK1 Cells; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Renin-Angiotensin System; Signal Transduction; Swine; Thymidine; Tritium; Tyrosine | 2001 |
IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathies; Diabetic Angiopathies; DNA; Insulin-Like Growth Factor I; Mice; Mice, Transgenic; Myocardium; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Tissue Distribution; Tumor Suppressor Protein p53; Tyrosine; Ventricular Function | 2001 |
Investigation of tyrosine nitration in proteins by mass spectrometry.
Topics: Affinity Labels; Angiotensin II; Hydrolysis; Indicators and Reagents; Mass Spectrometry; Nitrates; Proteins; Sequence Analysis, Protein; Serum Albumin, Bovine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trypsin; Tyrosine | 2001 |
Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.
Topics: Androstadienes; Angiotensin II; Animals; Binding Sites; Butadienes; Cell Line; Cell Nucleus; CHO Cells; Cricetinae; Cyclin D1; DNA Mutational Analysis; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Inhibitors; Genes, Dominant; Humans; Immediate-Early Proteins; Intracellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Nitriles; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Transcription Factors; Transcriptional Activation; Transfection; Tyrosine; Up-Regulation; Wortmannin | 2001 |
Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension.
Topics: Angiotensin II; Animals; Antibody Specificity; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Colforsin; Endothelium, Vascular; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphorylation; Phosphotyrosine; Physical Stimulation; Rats; Rats, Sprague-Dawley; Tyrosine; Tyrphostins; Vanadates; Vasoconstriction; Vasodilator Agents; Verapamil | 2001 |
Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Topics: Angiotensin II; Animals; Chromones; Collagen; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Leucine; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Morpholines; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Rats, Sprague-Dawley; src Homology Domains; Time Factors; Tritium; Tyrosine | 2001 |
Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Cyclic N-Oxides; Disease Models, Animal; Free Radical Scavengers; Free Radicals; Hypertension, Renovascular; Losartan; Male; Nephrectomy; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Artery; Renin; Spin Labels; Superoxides; Systole; Time Factors; Tyrosine | 2001 |
Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.
Topics: Angiotensin II; Animals; beta-Cyclodextrins; Caveolin 1; Caveolins; Cell Membrane; Cells, Cultured; Cholesterol; Cyclodextrins; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody Technique; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Phosphorylation; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Transcriptional Activation; Tyrosine | 2001 |
Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage.
Topics: Adrenal Glands; Adrenomedullin; Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Coronary Vessels; Female; Genotype; Lung; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 2; NADPH Oxidases; Peptide Fragments; Peptides; Phosphoproteins; Proteins; Reactive Oxygen Species; Sodium, Dietary; Time Factors; Tyrosine | 2002 |
Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Blood Vessels; Gene Expression; Humans; Hypertrophy; Immunohistochemistry; Luminescent Measurements; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; Oxidative Stress; Superoxide Dismutase; Superoxides; Tyrosine | 2002 |
Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Division; Cells, Cultured; Chromans; Depression, Chemical; DNA; Growth Substances; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thiazoles; Thiazolidinediones; Troglitazone; Tyrosine | 2002 |
Angiotensin II stimulates calcineurin activity in proximal tubule epithelia through AT-1 receptor-mediated tyrosine phosphorylation of the PLC-gamma1 isoform.
Topics: Angiotensin II; Animals; Calcineurin; Enzyme Activation; Epithelium; Isoenzymes; Kidney Tubules, Proximal; LLC-PK1 Cells; Phospholipase C gamma; Phosphorylation; Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Swine; Type C Phospholipases; Tyrosine | 2002 |
Role of pp60(c-src) and p(44/42) MAPK in ANG II-induced contraction of rat tonic gastrointestinal smooth muscles.
Topics: Angiotensin II; Animals; Antibodies; Benzoquinones; Calmodulin-Binding Proteins; Digestive System; Digestive System Physiological Phenomena; Enzyme Inhibitors; Female; Flavonoids; Genistein; In Vitro Techniques; Lactams, Macrocyclic; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Smooth; p120 GTPase Activating Protein; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins pp60(c-src); Quinones; Rats; Rats, Sprague-Dawley; Rifabutin; Tyrosine | 2002 |
A central role for Pyk2-Src interaction in coupling diverse stimuli to increased epithelial NBC activity.
Topics: Acidosis; Angiotensin II; Animals; Blotting, Western; Carbon Dioxide; Cell Line; Epithelial Cells; Fluorometry; Focal Adhesion Kinase 2; GTP-Binding Proteins; Hydrogen-Ion Concentration; Indicators and Reagents; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Opossums; Parasympathetic Nervous System; Parasympathomimetics; Phosphorylation; Precipitin Tests; Protein-Tyrosine Kinases; Signal Transduction; Sodium-Bicarbonate Symporters; Stimulation, Chemical; Tyrosine | 2002 |
Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Bungarotoxins; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Janus Kinase 2; Neuroprotective Agents; Nicotine; Nicotinic Agonists; PC12 Cells; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Receptors, Nicotinic; Serine; Signal Transduction; Tyrosine; Tyrphostins | 2002 |
Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors.
Topics: Angiotensin II; Animals; Antioxidants; Bacterial Toxins; Cells, Cultured; DNA-Binding Proteins; GTP-Binding Proteins; Humans; Janus Kinase 2; Muscle, Smooth, Vascular; Mutation; Oxidants; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; rac1 GTP-Binding Protein; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; rho GTP-Binding Proteins; Signal Transduction; STAT1 Transcription Factor; STAT2 Transcription Factor; STAT3 Transcription Factor; Thrombin; Trans-Activators; Transcription, Genetic; Tyrosine | 2003 |
Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species.
Topics: Angiotensin II; Animals; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Reactive Nitrogen Species; Tyrosine | 2003 |
High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway.
Topics: Acetophenones; Aldehyde Reductase; Angiotensin II; Animals; Antibodies; Aorta; Benzothiazoles; Cells, Cultured; Drug Synergism; Electroporation; Enzyme Inhibitors; Glucose; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Muscle, Smooth, Vascular; NADPH Oxidases; Oligonucleotides, Antisense; Phosphoproteins; Phosphorylation; Phthalazines; Polymers; Protein Kinase C; Protein Kinase C beta; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Reactive Oxygen Species; Thiazoles; Tyrosine; Vasoconstrictor Agents | 2003 |
An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells.
Topics: Adenoviridae; Angiotensin II; Animals; Aorta, Thoracic; Becaplermin; Blotting, Western; Bromodeoxyuridine; Cell Division; Cell Membrane; Cell Movement; Cells, Cultured; Cellular Apoptosis Susceptibility Protein; COS Cells; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Glutathione Transferase; Green Fluorescent Proteins; Immunohistochemistry; Luminescent Proteins; Mitogen-Activated Protein Kinases; Models, Biological; Muscle, Smooth; Paxillin; Phosphoproteins; Phosphorylation; Platelet-Derived Growth Factor; Precipitin Tests; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; rac1 GTP-Binding Protein; Rats; Recombinant Fusion Proteins; Tetrazolium Salts; Time Factors; Transfection; Tyrosine | 2003 |
Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney.
Topics: Angiotensin II; Animals; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Immunohistochemistry; Kidney; Male; Precipitin Tests; Rats; Rats, Wistar; Recombinant Proteins; Sensitivity and Specificity; Superoxide Dismutase; Tyrosine | 2003 |
S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2.
Topics: Angiotensin II; Animals; Antibodies; Aorta; Cell Division; Cells, Cultured; DNA-Binding Proteins; Drug Synergism; Electroporation; Hydrogen Peroxide; Janus Kinase 2; Ligands; Muscle, Smooth, Vascular; NADPH Oxidases; Phospholipase D; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins; STAT1 Transcription Factor; Trans-Activators; Tyrosine; Vasoconstrictor Agents | 2003 |
Suppressor of cytokine signaling 3 is induced by angiotensin II in heart and isolated cardiomyocytes, and participates in desensitization.
Topics: Angiotensin II; Animals; Heart; Janus Kinase 2; Male; Myocardium; Myocytes, Cardiac; Oligonucleotides, Antisense; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Repressor Proteins; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; Tissue Distribution; Transcription Factors; Tyrosine | 2003 |
Immunologic production of antiangiotensin. I. Preparation of angiotensin-protein complex antigen.
Topics: Amines; Angiotensin Amide; Angiotensin II; Angiotensins; Animals; Cattle; Dogs; Proteins; Tyrosine | 1960 |
IONIZATION OF TYROSYL GROUP IN ANGIOTENSIN II.
Topics: Angiotensin II; Angiotensins; Research; Spectrophotometry; Tyrosine | 1963 |
GIT1 mediates Src-dependent activation of phospholipase Cgamma by angiotensin II and epidermal growth factor.
Topics: Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Angiotensin II; Animals; Calcium; Cell Cycle Proteins; Cell Line; Cells, Cultured; Cloning, Molecular; DNA Mutational Analysis; Enzyme Activation; Epidermal Growth Factor; Gene Deletion; GTPase-Activating Proteins; Humans; Immunoblotting; Mass Spectrometry; Models, Biological; Models, Genetic; Molecular Sequence Data; Muscle, Smooth; Oligonucleotides; Peptides; Phospholipase C gamma; Phosphoproteins; Phosphorylation; Plasmids; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Rats; Sequence Homology, Amino Acid; Signal Transduction; src-Family Kinases; Transfection; Type C Phospholipases; Tyrosine | 2003 |
Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Angiotensin II; Animals; Base Sequence; Binding Sites; Cells, Cultured; DNA, Complementary; Focal Adhesion Kinase 2; Focal Adhesions; Muscle, Smooth, Vascular; Mutagenesis, Site-Directed; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Rats; Signal Transduction; src-Family Kinases; Tyrosine | 2003 |
Angiotensin II mediates Tyr-dephosphorylation in rat fetal kidney membranes.
Topics: Angiotensin II; Animals; Blotting, Western; Cell Membrane; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Female; Imidazoles; Immunoblotting; Kidney; Oligopeptides; Phosphorylation; Phosphotyrosine; Pyridines; Rats; Rats, Inbred WKY; Signal Transduction; Tyrosine; Vanadates | 2003 |
The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiotensin II; Animals; Apoptosis; Bridged Bicyclo Compounds; Drosophila Proteins; Enzyme Activation; Intracellular Signaling Peptides and Proteins; Janus Kinase 2; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Receptors, Nicotinic; Serine; Tyrosine; Tyrphostins | 2004 |
Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Topics: Angiotensin II; Animals; Cell Adhesion; Cell Movement; Cells, Cultured; Cellular Apoptosis Susceptibility Protein; Enzyme Activation; Genes, src; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphorylation; Rats; Rats, Sprague-Dawley; src-Family Kinases; Tyrosine; Vinculin | 2004 |
Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cyclic CMP; Humans; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Oocytes; Phenylalanine; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Receptor, Angiotensin, Type 2; Signal Transduction; Tyrosine; Xenopus | 2004 |
AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
Topics: Angiotensin II; Animals; Bridged Bicyclo Compounds, Heterocyclic; Crown Compounds; Dimethyl Sulfoxide; Dipeptides; Female; In Vitro Techniques; Liver; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Molecular Mimicry; Radioligand Assay; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Solutions; Structure-Activity Relationship; Swine; Tyrosine; Uterus | 2004 |
Jak2 tyrosine kinase residues glutamic acid 1024 and arginine 1113 form a hydrogen bond interaction that is essential for Jak-STAT signal transduction.
Topics: Alanine; Algorithms; Amino Acid Sequence; Angiotensin II; Animals; Arginine; Blotting, Western; Cell Line; COS Cells; Crystallography, X-Ray; Cytoplasm; DNA-Binding Proteins; Gene Expression Regulation; Genes, Dominant; Glutamic Acid; Hydrogen Bonding; Immunoprecipitation; Janus Kinase 2; Luciferases; Lysine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Phosphorylation; Protein Binding; Protein Conformation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Signal Transduction; STAT1 Transcription Factor; Structure-Activity Relationship; Trans-Activators; Transfection; Tyrosine | 2004 |
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents | 2004 |
Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Collagen; Humans; Hypertension; Kidney; Membrane Glycoproteins; Mice; Mice, Transgenic; Myocardium; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Renin; Tyrosine | 2005 |
Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II.
Topics: Angiotensin II; Animals; Annexin A2; Calcium; Cells, Cultured; Cyclooxygenase 2; Focal Adhesion Kinase 2; Humans; MAP Kinase Kinase 6; MAP Kinase Kinase Kinase 4; Membrane Proteins; Muscle, Smooth, Vascular; Oncogene Protein pp60(v-src); Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Rats; Signal Transduction; Transcription, Genetic; Tyrosine | 2005 |
ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Blood Vessels; Cell Membrane; Cytoplasm; Enzyme Activation; Enzyme Inhibitors; Glucose; Glucose Transporter Type 4; Hypertension; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monosaccharide Transport Proteins; Muscle Proteins; Myocytes, Smooth Muscle; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Serine; Tyrosine | 2005 |
Correction of endothelial dysfunction by tetrahydrobiopterin: new hope for the treatment of arterial hypertension?
Topics: Angiotensin II; Animals; Antioxidants; Biopterins; Cardiomegaly; Endothelium, Vascular; Hypertension; Immunohistochemistry; Male; Myocardium; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Tyrosine; Up-Regulation | 2005 |
Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress.
Topics: Acetophenones; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Biopterins; Cardiomegaly; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Immunohistochemistry; Male; NADPH Oxidases; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxides; Time Factors; Tyrosine; Up-Regulation | 2005 |
Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.
Topics: Actin Cytoskeleton; Angiotensin II; Animals; Caveolin 1; Cells, Cultured; ErbB Receptors; Hypertrophy; Membrane Microdomains; Muscle, Smooth, Vascular; NADPH Oxidases; Oxidation-Reduction; Phosphorylation; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Signal Transduction; SOS1 Protein; Tyrosine; Vasoconstrictor Agents | 2005 |
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents | 2005 |
Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molsidomine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Nitrates; Nitric Oxide Synthase; Rats; Receptor, Angiotensin, Type 1; Tyrosine | 2005 |
Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes.
Topics: Angiotensin II; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspases; Cell Line; Cells, Cultured; Electrophoretic Mobility Shift Assay; Janus Kinase 2; Myocytes, Cardiac; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Transfection; Tyrosine | 2005 |
Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys.
Topics: Angiotensin II; Animals; Aortic Coarctation; Chemokine CCL2; Flow Cytometry; Hydrogen Peroxide; Hypertension, Renovascular; Integrins; Kidney; Leukocytes; Lymphocytes; Macrophages; Male; Rats; Rats, Sprague-Dawley; Tyrosine | 2005 |
Mapping sites of tyrosine nitration by matrix-assisted laser desorption/ionization mass spectrometry.
Topics: Angiotensin II; Humans; Nitrates; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine | 2005 |
Differential regulation of Pyk2 phosphorylation at Tyr-402 and Tyr-580 in intestinal epithelial cells: roles of calcium, Src, Rho kinase, and the cytoskeleton.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Cytoskeleton; Focal Adhesion Kinase 2; Humans; Intestinal Mucosa; Intracellular Signaling Peptides and Proteins; Phosphorylation; Protein Serine-Threonine Kinases; rho-Associated Kinases; Signal Transduction; src-Family Kinases; Tyrosine | 2006 |
Effect of inhibition of nitric oxide synthase on renal cyclooxygenase in the diabetic rat.
Topics: Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Blotting, Western; Body Weight; Cyclooxygenase 1; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Enzyme Inhibitors; In Vitro Techniques; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Pressure; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Wistar; Tyrosine | 2006 |
Peptide ozonolysis: product structures and relative reactivities for oxidation of tyrosine and histidine residues.
Topics: Angiotensin II; Computer Simulation; Histidine; Models, Chemical; Models, Molecular; Oxidation-Reduction; Ozone; Peptides; Spectrometry, Mass, Electrospray Ionization; Tyrosine | 2006 |
An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Cardiomegaly; Diastole; Echocardiography; ErbB Receptors; Fibrosis; Genes, Dominant; Heart; Mice; Mice, Transgenic; Mutation; Myocardium; Phenylalanine; Receptor, Angiotensin, Type 1; Transcriptional Activation; Tyrosine; Ventricular Function, Left | 2006 |
Angiotensin II modulates tyr-phosphorylation of IRS-4, an insulin receptor substrate, in rat liver membranes.
Topics: Androstadienes; Angiotensin II; Animals; Cell Membrane; Genistein; Insulin; Insulin Receptor Substrate Proteins; Liver; Male; Okadaic Acid; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Tyrosine; Vasoconstrictor Agents; Wortmannin | 2006 |
Adrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activity.
Topics: Adrenomedullin; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Calcitonin Gene-Related Peptide; Cells, Cultured; CSK Tyrosine-Protein Kinase; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Male; Muscle, Smooth, Vascular; Oxidative Stress; Peptide Fragments; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Tyrosine; Vasoconstrictor Agents | 2007 |
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Fibroblasts; Interleukin-6; Janus Kinases; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Culture Techniques; Phosphorylation; Receptors, LDL; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Tyrosine; Vasoconstrictor Agents | 2007 |
Nitrite-assisted peptide iodination and conjugation.
Topics: Angiotensin II; Animals; Cattle; Cytochromes c; Histidine; Indicators and Reagents; Insulin; Iodine; Mass Spectrometry; Myocardium; Nitrites; Peptides; Tyrosine | 2007 |
Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Cerebrovascular Circulation; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrosation; Peroxynitrous Acid; Reactive Oxygen Species; Superoxides; Tyrosine; Vasodilator Agents; Vibrissae | 2007 |
Enalapril improves impairment of SERCA-derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Enalapril; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Peroxynitrous Acid; Rats; Rats, Wistar; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Thapsigargin; Tyrosine | 2007 |
Reduction of the nitro group during sample preparation may cause underestimation of the nitration level in 3-nitrotyrosine immunoblotting.
Topics: Analytic Sample Preparation Methods; Angiotensin II; Animals; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Immunoblotting; Immunohistochemistry; Liver; Lung; Oxidation-Reduction; Rats; Serum Albumin; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine | 2007 |
Investigation of tyrosine nitration and nitrosylation of angiotensin II and bovine serum albumin with electrospray ionization mass spectrometry.
Topics: Angiotensin II; Nitrates; Nitrogen; Reproducibility of Results; Sensitivity and Specificity; Serum Albumin, Bovine; Spectrometry, Mass, Electrospray Ionization; Tyrosine | 2007 |
Lead exposure effect on angiotensin II renal vasoconstriction.
Topics: Administration, Oral; Angiotensin II; Animals; Blotting, Western; Dose-Response Relationship, Drug; Endothelial Cells; Immunohistochemistry; In Vitro Techniques; Injections; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organometallic Compounds; Papaverine; Perfusion; Rats; Rats, Wistar; Renal Artery; Superoxides; Tyrosine; Vasoconstriction | 2007 |
Determination of the structure of lipid vesicle-bound angiotensin II and angiotensin I.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Deuterium Exchange Measurement; Liposomes; Phospholipids; Protein Conformation; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry; Tyrosine | 2008 |
Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Aorta; Cells, Cultured; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertrophy; Immunoblotting; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Kinase C-delta; Rats; Receptor, Angiotensin, Type 1; src-Family Kinases; Tyrosine | 2008 |
Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
Topics: Acetylcholine; Angiotensin II; Animals; Biopterins; Biosensing Techniques; Blood Pressure; Calibration; Catheterization; Enzyme Inhibitors; Heart Rate; Hypoglycemic Agents; Immunohistochemistry; Male; Nitric Oxide; omega-N-Methylarginine; Pioglitazone; PPAR gamma; Rabbits; Thiazolidinediones; Tyrosine; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42/44 mitogen-activated protein kinase.
Topics: Angiotensin II; Animals; Butadienes; Cells, Cultured; Enzyme Activation; Ethanol; Hepatocytes; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Serine; STAT3 Transcription Factor; Time Factors; Tyrosine | 2008 |
Differential phosphorylation of calreticulin affects AT1 receptor mRNA stability in VSMC.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Calreticulin; Cantharidin; Cells, Cultured; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Rats; Receptor, Angiotensin, Type 1; RNA Stability; Serine; src-Family Kinases; Tyrosine | 2008 |
G-protein-coupled receptor-mediated traffic of Na,K-ATPase to the plasma membrane requires the binding of adaptor protein 1 to a Tyr-255-based sequence in the alpha-subunit.
Topics: Adaptor Protein Complex 1; Angiotensin II; Animals; Cell Line; Cell Membrane; Enzyme Activation; Mutation; Opossums; Phenylalanine; Protein Binding; Protein Conformation; Rats; Sodium-Potassium-Exchanging ATPase; Transfection; Tyrosine | 2008 |
Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Endothelial Cells; Endothelin-1; Epoprostenol; Free Radical Scavengers; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophils; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptides; Protein Kinase Inhibitors; Time Factors; Tyrosine; Up-Regulation | 2008 |
Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Dose-Response Relationship, Drug; Growth; Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Peptide Fragments; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Signal Transduction; STAT3 Transcription Factor; STAT5 Transcription Factor; Tyrosine | 2008 |
Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzhydryl Compounds; Cricetinae; Cystinyl Aminopeptidase; Ligands; Peptides; Receptors, Angiotensin; Tyrosine | 2008 |
Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
Topics: Aldehydes; Angiotensin II; Animals; Antioxidants; Arterioles; Body Weight; Cyclic N-Oxides; Disease Models, Animal; Glomerular Filtration Rate; Hypertension, Renal; Hyperuricemia; Kidney Glomerulus; Male; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Oxonic Acid; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Superoxides; Tyrosine | 2008 |
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
Topics: Angiotensin II; Cell Nucleus; Cells, Cultured; Diabetic Nephropathies; Epithelial Cells; Gene Expression; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; NF-kappa B; Oxidative Stress; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rosiglitazone; Thiazolidinediones; Tyrosine | 2008 |
Chronic production of peroxynitrite in the vascular wall impairs vasorelaxation function in SHR/NDmcr-cp rats, an animal model of metabolic syndrome.
Topics: Acetylcholine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Vessels; Blotting, Western; Enzyme Activation; Immunoenzyme Techniques; Luminescence; Male; Metabolic Syndrome; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroprusside; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; Tyrosine; Vasoconstrictor Agents; Vasodilation | 2009 |
Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Aorta; Biopterins; Blood Pressure; Cells, Cultured; Cysteine Proteinase Inhibitors; Endothelial Cells; Endothelium, Vascular; GTP Cyclohydrolase; Humans; Hypertension; In Vitro Techniques; Leupeptins; Mice; Mice, Inbred C57BL; Nitrates; Peroxynitrous Acid; Proteasome Endopeptidase Complex; Proteasome Inhibitors; RNA, Small Interfering; Transfection; Tyrosine; Vasodilation | 2009 |
Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cerebral Arteries; Chemokine CCL2; Eplerenone; Female; Gene Expression; Hypertension, Renal; Immunohistochemistry; Intracranial Aneurysm; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Ovariectomy; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tyrosine | 2009 |
A protein tyrosine phosphatase inhibitor, pervanadate, inhibits angiotensin II-Induced beta-arrestin cleavage.
Topics: Angiotensin II; Animals; Arrestins; beta-Arrestin 1; beta-Arrestins; Blotting, Western; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Enzyme Inhibitors; Green Fluorescent Proteins; Hydrolysis; Molybdenum; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatases; Rats; Receptor, Angiotensin, Type 1; Transfection; Tyrosine; Vanadates; Vasoconstrictor Agents | 2009 |
PYK2/PDZ-RhoGEF links Ca2+ signaling to RhoA.
Topics: 3T3-L1 Cells; Angiotensin II; Animals; Calcium Signaling; Cells, Cultured; Chlorocebus aethiops; COS Cells; Focal Adhesion Kinase 2; Guanine Nucleotide Exchange Factors; Mice; Phosphorylation; Rats; Rats, Sprague-Dawley; RGS Proteins; rhoA GTP-Binding Protein; Tyrosine | 2009 |
Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase.
Topics: Angiotensin II; Animals; Cells, Cultured; Endothelial Cells; Focal Adhesion Kinase 2; Humans; Hydrogen Peroxide; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Tyrosine; Vasodilation | 2009 |
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Fumarates; Glomerular Filtration Rate; Hypertension; Irbesartan; Kidney; Membrane Glycoproteins; Membrane Proteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Podocytes; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Tyrosine | 2010 |
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.
Topics: Angiotensin II; Animals; Blood Pressure; Guanine Nucleotide Exchange Factors; Hypertension; Janus Kinase 2; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Phosphorylation; Proto-Oncogene Proteins; Rho Guanine Nucleotide Exchange Factors; Signal Transduction; Tyrosine | 2010 |
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Heart Atria; Humans; Lymphocyte Activation; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neutrophils; Peroxidase; Tyrosine | 2010 |
Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.
Topics: Angiotensin II; Animals; Cells, Cultured; Glucose Transporter Type 4; Humans; Insulin; Insulin Receptor Substrate Proteins; Mitogen-Activated Protein Kinase 3; Muscle Fibers, Skeletal; Muscle, Skeletal; Nitrates; Protein Transport; Proto-Oncogene Proteins c-akt; Rats; Tyrosine | 2010 |
Efficient identification and quantification of peptides containing nitrotyrosine by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry after derivatization.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Cattle; Molecular Sequence Data; Peptides; Serum Albumin, Bovine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine | 2010 |
Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
Topics: Angiotensin II; Antioxidants; Bilirubin; Biliverdine; Cytoprotection; Endothelial Cells; Free Radical Scavengers; Gene Knockdown Techniques; Gene Silencing; Heme Oxygenase-1; Humans; Leukocytes; Lipopolysaccharides; Mitochondria; Models, Biological; Neutrophils; Nitrosation; Oxidoreductases Acting on CH-CH Group Donors; Peroxynitrous Acid; Reactive Oxygen Species; Respiratory Burst; Tyrosine; Umbilical Veins; Xanthine Oxidase | 2010 |
Attenuated cardiovascular hypertrophy and oxidant generation in response to angiotensin II infusion in glutaredoxin-1 knockout mice.
Topics: Actin Cytoskeleton; Angiotensin II; Animals; Aorta; Cardiovascular Diseases; Cell Line; Glutaredoxins; Hypertrophy; Infusion Pumps; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nitric Oxide Synthase Type II; Oncogene Protein v-akt; Oxidants; RNA, Small Interfering; Tyrosine | 2010 |
Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP).
Topics: Angiotensin II; Animals; CD13 Antigens; Cell Line; Chelating Agents; CHO Cells; Cricetinae; Cricetulus; Cystinyl Aminopeptidase; Mice; Organophosphorus Compounds; Radioligand Assay; Tyrosine; Zinc | 2012 |
Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.
Topics: Aminopeptidases; Angiotensin II; Animals; Biocatalysis; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; HEK293 Cells; Humans; Molecular Structure; Phenylalanine; Proline; Protein Conformation; Spectrophotometry, Atomic; Substrate Specificity; Tyrosine | 2011 |
Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Hypertension; Kidney; Kidney Function Tests; Male; Neprilysin; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Transcription, Genetic; Tyrosine | 2011 |
PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling?
Topics: Angiotensin II; Blotting, Western; Cells, Cultured; Fibroblasts; Humans; Phospholipase C beta; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Receptor, Angiotensin, Type 1; RGS Proteins; Signal Transduction; Tyrosine; Vanadates | 2011 |
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Cells, Cultured; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Insulin; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Losartan; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Serine; Signal Transduction; Tyrosine | 2011 |
ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Blotting, Western; Chemokine CCL2; Ethidium; Inflammation; Interleukin-1beta; Interleukin-6; Mice; Mice, Knockout; NADPH Oxidases; Peptidyl-Dipeptidase A; Peroxynitrous Acid; Profilins; Real-Time Polymerase Chain Reaction; Tyrosine | 2012 |
Preconditioning protects the heart in a prolonged uremic condition.
Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Stroke Volume; Time Factors; Tyrosine; Ultrasonography; Urea; Uremia; Uric Acid; Ventricular Function, Left | 2012 |
Phosphorylation of myocardial eNOS is altered in patients suffering from type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Diabetes Mellitus, Type 2; Dinoprost; Humans; Middle Aged; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Tyrosine | 2013 |
Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Drug Synergism; Endothelium, Vascular; Losartan; Male; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitroprusside; Phenylephrine; Pioglitazone; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Systole; Thiazolidinediones; Tyrosine; Vasoconstriction; Vasodilation | 2014 |
Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells.
Topics: Angiotensin II; Animals; Cattle; Cell Line; Endothelial Cells; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Mice, Transgenic; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Zucker; Serine; Tetradecanoylphorbol Acetate; Threonine; Tyrosine | 2013 |
Ligand-directed selective protein modification based on local single-electron-transfer catalysis.
Topics: Angiotensin II; Animals; Carbonic Anhydrases; Catalysis; Cattle; Cells, Cultured; Electron Transport; Electrons; Erythrocytes; Female; Fluorescent Dyes; Free Radical Scavengers; Mice; Molecular Structure; Pyridines; Ruthenium; Serum Albumin, Bovine; Tyrosine | 2013 |
Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.
Topics: Angiotensin II; Animals; Catalase; Cytochrome P-450 CYP1B1; Disease Models, Animal; Drinking; Estradiol; Female; Fibrosis; Genotype; Hypertension; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Natriuresis; Oxidative Stress; Phenotype; Renin-Angiotensin System; Sex Factors; Superoxide Dismutase; Superoxides; Tyrosine; Urination | 2015 |
Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Topics: Adrenal Glands; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Eplerenone; Heart Diseases; Hypertension; Lipid Peroxidation; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Oxidative Stress; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction; Spironolactone; Time Factors; Tyrosine | 2015 |
Novel Roles for Peroxynitrite in Angiotensin II and CaMKII Signaling.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line; Methionine; Myocytes, Cardiac; Neurons; Oxidation-Reduction; Peroxynitrous Acid; Phosphorylation; Rats; Reactive Oxygen Species; Signal Transduction; Tyrosine | 2016 |
Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Blotting, Western; Collagen Type IV; Deoxyguanosine; Enzyme-Linked Immunosorbent Assay; Fibronectins; Immunohistochemistry; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Superoxide Dismutase; Transforming Growth Factor beta; Tyrosine | 2016 |
Specific enrichment of a targeted nitrotyrosine-containing peptide from complex matrices and relative quantification for liquid chromatography-mass spectrometry analysis.
Topics: Acetylation; Angiotensin II; Chromatography, Liquid; Humans; Hydrolysis; Mass Spectrometry; Nitro Compounds; Peptides; Serum Albumin, Bovine; Tyrosine | 2017 |
Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice.
Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Arterial Pressure; Cyclic GMP; Disease Models, Animal; Endothelium, Vascular; Hypertension; Male; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidase 4; Nitric Oxide; Oxidative Stress; Renal Artery; Sodium Nitrite; Tyrosine; Vasodilation | 2018 |
A Systems Biology Approach to Investigating Sex Differences in Cardiac Hypertrophy.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Models, Animal; Female; Gene Expression Regulation; Gene Regulatory Networks; Male; Mice, Inbred C57BL; MicroRNAs; Myocardium; Oxazoles; PPAR alpha; Protein Interaction Maps; RNA, Messenger; Sex Characteristics; Sex Factors; Signal Transduction; Systems Biology; Time Factors; Tyrosine | 2017 |
Binding Loop Substitutions in the Cyclic Peptide SFTI-1 Generate Potent and Selective Chymase Inhibitors.
Topics: Amino Acid Substitution; Angiotensin II; Chymases; Crystallography, X-Ray; Drug Design; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Dynamics Simulation; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Serine Proteinase Inhibitors; Small Molecule Libraries; Structure-Activity Relationship; Tyrosine | 2020 |